potential molecular mechanism 
 exercise reverse insulin 
 resistance improve 
 neurodegenerative disease 
 jiawen shen1† xianping wang2† Minghui wang3 
 Hu zhang3 
 1taizhou Hospital Zhejiang Province Afﬁliated Wenzhou Medical University Taizhou China 2school 
 Medicine Taizhou University Taizhou China 3college Sports Medicine Wuhan Sports University 
 Wuhan China 
 Neurodegenerative disease debilitate nervous system disorder attribute 
 condition body aging gene mutation genetic factor 
 immune system disorder prominent neurodegenerative disease include 
 Alzheimer disease Parkinson disease Huntington disease amyotrophic 
 lateral sclerosis multiple sclerosis insulin resistance refer inability 
 peripheral central tissue body respond insulin 
 effectively regulate blood sugar level insulin resistance observe 
 neurodegenerative disease suggest induce 
 occurrence development exacerbation neurodegenerative disease 
 furthermore increase number study suggest reverse 
 insulin 
 resistance 
 
 
 
 critical 
 intervention 
 
 
 treatment 
 
 neurodegenerative disease numerous measure available 
 improve insulin sensitivity exercise widely accept strategy 
 convenience 
 affordability 
 
 signiﬁcant 
 impact 
 
 increase 
 insulin 
 sensitivity review examine association neurodegenerative 
 disease insulin resistance highlight molecular mechanism 
 exercise reverse insulin resistance condition 
 focus regulate insulin resistance exercise provide 
 practical idea suggestion future research focus exercise- 
 induced insulin sensitivity context neurodegenerative disease 
 keywords 
 exercise insulin resistance alzheimer disease Parkinson disease huntington 
 disease amyotrophic lateral sclerosis multiple sclerosis 
 1 Introduction 
 Research statistic suggest old population certain country increase 
 approximately 11 1950 estimate 38 2030 number old 
 individual far exceed young individual 2050 United Nations Population 
 Division 2002 Rudnicka et al. 2020 chronic disease occur individual 
 increase incidence neurodegenerative condition attract 
 attention researcher country number individual dementia 
 include preclinical Alzheimer disease ad preclinical ad ad estimate 
 collectively account 22 global population aged ≥50 year Gustavsson et al. 
 2023 similarly epidemiological statistic neurodegenerative disease indicate 
 open access 
 edited 
 Luodan Yang 
 South China Normal University China 
 REVIEWED 
 Susana Cardoso 
 University Coimbra Portugal 
 Sandeep Kumar Singh 
 Indian Scientiﬁc Education Technology 
 Foundation India 
 Zhiwen Luo 
 Fudan University China 
 correspondence 
 Minghui Wang 
 wangminghui290335@163.com 
 Hu Zhang 
 huzhang0703@163.com 
 †these author contribute equally 
 work 
 received 13 November 2023 
 accepted 29 April 2024 
 published 16 2024 
 CITATION 
 Shen J Wang X Wang M Zhang H 2024 
 potential molecular mechanism exercise 
 reversing insulin resistance improve 
 neurodegenerative disease 
 physiol 15:1337442 
 doi 10.3389/fphys.2024.1337442 
 copyright 
 © 2024 Shen Wang Wang Zhang 
 open-access article distribute term 
 Creative Commons Attribution License 
 cc use distribution reproduction 
 forum permit provide original 
 author(s copyright owner(s 
 credit original publication 
 journal cite accordance accept 
 academic practice use distribution 
 reproduction permit 
 comply term 
 Frontiers Physiology 
 frontiersin.org 
 01 
 type review 
 published 16 2024 
 DOI 10.3389/fphys.2024.1337442 
 global proportion patient Parkinson disease pd 
 reach 12 million 2040 Dorsey et al. 2018 
 currently 
 multiple 
 sclerosis 
 ms 
 affect 
 approximately 
 2.8 
 million 
 individual 
 worldwide 
 
 Lancet 
 2021 
 
 comparison global incidence rate Huntington disease 
 hd amyotrophic lateral sclerosis als estimate 
 0.48 4.42 case 100,000 individuals/year respectively Xu 
 et al. 2020 Medina et al. 2022 2015 worldwide cost ad 
 prevention treatment reach us$ 957.56 billion 
 expect escalate us$ 9.12 trillion 2050 Jia et al. 2018 
 Neurodegenerative disease progressively deteriorate quality 
 life affect individual family increase related 
 medical cost social burden monoclonal antibody 
 Jia et al. 2018 drug levodopa LeWitt 2015 
 tetrabenazine Frank et al. 2016 edaravone rothstein 
 2017 
 
 regularly 
 develop 
 
 treat 
 common 
 neurodegenerative disease clinical trial development 
 cost issue associate certain antibody drug 
 limited 
 
 number 
 
 beneﬁciarie 
 
 
 intervention 
 identify safe reliable treatment 
 assist rehabilitation pathway vital address 
 issue 
 additionally 
 
 occurrence 
 development 
 
 progression 
 
 neurodegenerative 
 disease 
 involve 
 complex 
 mechanism target exploration relevant 
 mechanism 
 
 intervention 
 target 
 
 
 critical 
 
 alleviate neurodegenerative disease improve patient 
 recovery chronic inﬂammation cause aging chronic 
 disease lead peripheral central insulin resistance 
 ultimately 
 affect 
 synaptic 
 plasticity 
 neurotransmitter 
 transport neuronal survival Shonesy et al. 2012 Song et al. 
 2015 increase risk neurological disease lead 
 alteration learning cognition dietary function phillip 
 et al. 2018 wijtenburg et al. 2019 Cuperfain et al. 2020 damage 
 early metabolic function essential induction 
 exacerbation neurological disease Fakih et al. 2022 
 insulin resistance standard feature Reyes et al. 1984 
 Poewe Seppi 2017 ruiz-argüelle et al. 2018 Cordeiro et al. 
 2020 Kellar Craft 2020 increase insulin level enhance 
 insulin sensitivity regulate blood glucose level ameliorate 
 neurodegenerative disease wen et al. 2017 Aziz et al. 2020 
 Siddiqui et al. 2021 figure 1a safe effective 
 economical insulin-sensitizing intervention useful strategy 
 prevention treatment neurodegenerative disease 
 presently physical exercise promote modern society 
 method healthcare disease prevention extensively 
 accept public exhibit beneﬁcial effect context 
 chronic disease furthermore numerous study 
 demonstrate 
 
 exercise 
 
 enhance 
 insulin 
 sensitivity 
 Angulo et al. 2020 suggest increase insulin 
 sensitivity 
 
 exercise 
 
 prevent 
 
 ameliorate 
 neurodegenerative disease review elucidate relatively 
 complex critical molecular mechanism involve insulin 
 resistance neurodegenerative disease exercise-induced 
 enhancement insulin sensitivity provide scientiﬁc 
 perspective signiﬁcance exercise-reversed insulin 
 resistance neurodegenerative disease ultimately 
 contribute prevention treatment neurodegenerative 
 disease increasingly old population 
 2 Insulin resistance 
 discovery insulin 1921 notable 1962 study 
 Rabinowitz Zierler observe exogenous insulin promote 
 glucose uptake obese individual furthermore observe 
 exogenous insulin enhance ability adipose tissue absorb 
 glucose simultaneously inhibit release free fatty acid 
 adipose tissue effect signiﬁcantly weak 
 individual obesity general population Rabinowitz 
 Zierler 1962 follow prominent ﬁnding insulin 
 resistance gradually emerge popular research topic 
 ﬁeld human health 
 advent Second Industrial Revolution rapidly 
 increase availability good production human life 
 advancement lead increase energy consumption 
 reduce physical labor result obesity type 2 diabetes- 
 related metabolic disease high incidence chronic disease 
 provide adequate condition insulin resistance 
 mechanism underlie insulin resistance 
 explore occur multiple tissue body organ 
 include skeletal muscle liver brain fat tissue insulin 
 secrete pancreatic islet transport circulatory 
 system muscle tissue cell insulin molecule target 
 insulin 
 receptor 
 insr 
 
 cell-surface 
 heterotetramer 
 transmembrane receptor compose α- β- 
 subunit 
 subsequently 
 
 intracellular 
 pi3k/akt/glucose 
 transporter type 4 glut4 signaling pathway activate 
 recruitment 
 
 phosphorylation 
 
 
 facilitate 
 
 transport plasma glucose muscle fat cell glucose 
 transport provide energy intracellular activity help 
 low blood sugar level figure 1b Lee Pilch 1994 Kahn 
 1996 pessin et al. 1999 recent study report insulin 
 resistance primarily cause inability insulin effectively 
 activate insulin receptor substrate irs reduce IRS 
 activation weaken glut4 function context glucose 
 transport additionally decrease ability irs-1/2 
 effectively activate glycogen uptake liver hinder glycogen 
 synthesis abnormality ultimately lead elevated blood glucose 
 level Li et al. 2022 inﬂammation shoelson et al. 
 2006 oxidative stress evan et al. 2005 decrease mitochondrial 
 function Sangwung et al. 2020 circadian rhythm imbalance 
 stenver et al. 2019 intestinal ﬂora disorder Lee et al. 2020 
 endoplasmic reticulum stress sims-robinson et al. 2016 
 identiﬁed essential insulin resistance factor speciﬁc 
 cause insulin resistance remain unclear Figure 1C 
 furthermore insulin resistance alter balance 
 glucose consumption supply ultimately result high 
 blood sugar level turn promote disease 
 metabolic syndrome robert et al. 2013 cancer robert et al. 
 2013 coronary heart disease Zhang Y. et al. 2022 ad Talbot 
 et al. 2012 pd Athauda Foltynie 2016 currently 
 physical exercise diet control drug intervention 
 accept primary mean increase insulin sensitivity insulin 
 resistance diagnose dynamic test simple index 
 biochemical marker Borai et al. 2011 include dynamic 
 hyperinsulinemic-euglycemic 
 clamp 
 frequent 
 sampling 
 intravenous glucose tolerance test relatively simple fast 
 insulin level glucose tolerance test glycated hemoglobin 
 Frontiers Physiology 
 frontiersin.org 
 02 
 Shen et al. 
 10.3389/fphys.2024.1337442 
 fasting blood glucose insulin resistance index biological 
 indicator leptin adiponectin triglyceride high-density 
 lipoprotein 
 
 cholesterol 
 
 
 relevant 
 prediction 
 judgment 
 3 Exercise nervous system insulin 
 resistance 
 human central nervous system require approximately 20 
 approximately 120–130 g available glucose maintain 
 biological activity include body movement physiological 
 reaction holliday 1971 intricate dynamic learning 
 memory formation critical brain function insulin 
 vital facilitator ensure efﬁcient uptake glucose 
 brain adequately meet heightened energy demand Yano et al. 
 1991 Emmanuel et al. 2013 previous study incorrectly assume 
 brain insensitive insulin produce insulin 
 later study establish brain regulate 
 insulin demonstrate occurrence insulin resistance 
 brain Margolis Altszuler 1967 Havrankova et al. 1978 
 furthermore insulin intervention peripheral lv et al. 
 2020 central nervous system Moosavi et al. 2006 rat 
 mouse signiﬁcantly alleviate neurological disease 
 insulin signaling activation potential molecular mechanism 
 Insulin detect cerebrospinal ﬂuid human 
 animal conﬁrme insulin role nervous 
 system increase peripheral insulin related 
 selectivity saturability active transport blood brain 
 barrier vascular endothelium Margolis Altszuler 1967 
 Baura et al. 1993 bank et al. 1997 wood et al. 2003 
 expression insulin mrna brain tissue 
 remain controversial Arnold et al. 2018 study 
 employ Cre/LoxP technology knock insr mouse brain 
 substantiate critical role insulin brain 
 investigation demonstrate signiﬁcant increase neuronal 
 apoptosis signiﬁcant decrease downstream Akt 
 gsk3β phosphorylation level insulin resistance ad-related 
 anxiety depression Brüning et al. 2000 Schubert et al. 2004 
 Kleinridders et al. 2015 indicate potential link high 
 insulin level synapsis essential role Werther et al. 
 1989 Abbott et al. 1999 Bockmann et al. 2002 researcher 
 observe insr expression different brain area include 
 cortex hippocampus hypothalamus cerebellum Zhao et al. 
 2004 Dou et al. 2005 Fernandez Torres-Alemán 2012 
 current research suggest insulin resistance 
 occur nervous system associate 
 neurological disease 
 Exercise increase energy consumption body 
 signiﬁcantly accelerate glucose expenditure liver fat storage 
 tissue enhance glucose transport utilization 
 cell crucial brain cognition Malin et al. 2022 
 nervous system susceptible glucose insulin resistance 
 result poor learning memory ability neuronal 
 FIGURE 1 
 Detection method molecular mechanism potential induce factor insulin resistance insulin detection method disease 
 potentially cause hyperglycemia b1 insulin resistance liver induce irs/pi3k/akt inhibit lipid protein glycogen synthesis b2 insulin 
 resistance skeletal muscle impair ability glut4 transport extra-cellular glucose muscle cell c potential inducer insulin 
 resistance liver skeletal muscle 
 Frontiers Physiology 
 frontiersin.org 
 03 
 Shen et al. 
 10.3389/fphys.2024.1337442 
 degeneration line notion previous study indicate 
 insulin injection elevate insulin level enhance learning 
 memory ability healthy young man exercise activity 
 yield similar outcome Zhang H. et al. 2022 Abbasi et al. 2023 
 furthermore short-term intermittent exercise individual 
 insulin resistance increase glucose uptake metabolism 
 brain additionally 8-week aerobic exercise intervention 
 increase insulin sensitivity individual classiﬁed overweight 
 sedentary obese insulin resistance animal study 
 reveal middle-aged rat exhibit certain degree insulin 
 resistance Kuga et al. 2018 exercise alleviate cognitive 
 dysfunction t2dm rat activate insulin signaling 
 pathway Rahmati et al. 2021 finally exercise-enhanced insulin 
 signaling 
 play 
 
 vital 
 role 
 
 neurodegenerative 
 disease 
 Mahalakshmi et al. 2020 accord result exercise 
 effectively improve insulin resistance central nervous system 
 
 signiﬁcantly 
 positively 
 affect 
 learning 
 cognition 
 
 prevention neurological disease 
 4 Insulin resistance 
 neurodegenerative disease 
 Neurodegenerative disease typically cause aging 
 increase number study observe 
 insulin 
 signaling 
 elicit 
 abnormal 
 change 
 involved 
 
 
 occurrence 
 
 development 
 
 multiple 
 neurodegenerative 
 disease downregulation insr failure insr 
 bind insulin impairment insulin cascade occur 
 different neurodegenerative disease employ 
 disease-centered system elucidate mechanism underlie 
 ir common neurodegenerative disease 
 4.1 Insulin resistance Alzheimer 
 disease ad 
 ad common neurodegenerative disease signiﬁcantly 
 affect quality life old adult worldwide present ad 
 pathogenesis mechanism primarily involve excessive amyloid beta 
 aβ deposition tau protein phosphorylation factor 
 potentially related insulin resistance Kakoty et al. 2023a 
 Insulin resistance signiﬁcantly increase brain normal- 
 aging wild-type app/ps1 mouse Denver et al. 2018 
 furthermore signiﬁcant decrease brain glucose utilization 
 assess 18f-fdg report ad model 
 Waldron et al. 2015 multiple study demonstrate 
 intranasal insulin intervention enhance cognitive performance 
 individual ad schiöth et al. 2012 Agrawal et al. 2018 
 investigation conduct utilize ad model 
 illuminate issue certain study outcome 
 optimal medical imaging ﬁnding provide evidence 
 association insulin resistance degeneration brain 
 structure Benedict et al. 2012 Cui et al. 2022 
 study demonstrate insulin primarily inﬂuence 
 neuron insulin/irs/akt pathway mapk 
 cascade insulin resistance induce aggravate ad 
 development inhibit pi3k/akt wnt signaling 
 pathway activate gsk3β crucial initiator tau protein 
 phosphorylation doble Woodgett 2003 Schubert et al. 2003 
 additionally abnormal tau gene expression associate 
 impaired insulin signaling tau phosphorylation 
 enhance insulin resistance-induced increase 
 oxidative stress inﬂammation Schubert et al. 2004 
 researcher observe deletion loss function tau 
 protein lead metabolic/brain insulin resistance damage 
 plasticity hippocampal neuron marciniak et al. 2017 
 
 insulin 
 resistance 
 
 escalate 
 tau 
 protein 
 hyperphosphorylation certain extent induce 
 exacerbating ad create vicious cycle furthermore tau 
 protein hyperphosphorylation critical promote neurological 
 disease tau protein loss result pd development 
 pd mouse Lei et al. 2012 reduce tau protein 
 hyperphosphorylation restore insulin signaling vital 
 preventive measure neurodegenerative disease 
 aβ deposition human ad brain positively correlate 
 peripheral insulin resistance insulin resistance 
 precede condition aβ deposition Willette et al. 2015 
 excessive Aβ inhibit insulin binding ability insrs 
 extent exacerbate insulin resistance xie et al. 
 2002 activate jnk/tnf-α pathway induce irs-1 
 phosphorylation Bomﬁm et al. 2012 Yoon et al. 2012 
 alteration turn lead increase aβ deposition form 
 harmful loop intranasal insulin administration decrease Aβ 
 level 3xtg-ad mouse brain Chen et al. 2014 reduction 
 aβ accumulation observation activate 
 insulin signaling pathway improve aβ precursor protein transport 
 metabolism erk/mapk signaling pathway 
 regulation α β γ secretase Gasparini et al. 2001 
 Gasparini et al. 2002 Cai et al. 2015 conversely human 
 study report insulin-activated signaling pathway 
 increase aβ secretion level cerebrospinal ﬂuid Watson et al. 
 2003 accelerate aβ clearance brain reduce plasma aβ 
 level figure 2a Reger et al. 2008a contrast 
 result ascribe difference ﬁnding 
 obtain model tissue sample 
 efﬁcacy insulin efﬁcacy treat ad 
 related apoe-ε4 gene insulin intervention signiﬁcantly 
 improve patient carry apoe-ε4 gene 
 exhibit signiﬁcant improvement general efﬁcacy 
 worsen Reger et al. 2008b consequently development 
 insulin resistance treatment ad serve target 
 treatment strategy modulate insulin level 
 require comprehensive judgment imply non- 
 insulin pathway modulate insulin signaling pathway 
 helpful approach alleviate ad 
 4.2 Insulin resistance Parkinson 
 disease pd 
 PD second common neurodegenerative disease 
 
 signiﬁcantly 
 increase 
 occurrence 
 
 individual 
 aged > 65 year trend related increase 
 availability 
 
 industrial 
 product 
 
 
 change 
 
 environmental factor patient pd primarily present 
 Frontiers Physiology 
 frontiersin.org 
 04 
 Shen et al. 
 10.3389/fphys.2024.1337442 
 resting tremor body stiffness abnormal walk posture gait 
 cognitive impairment pd pathophysiology likely link 
 dysfunction loss dopaminergic neuron α- 
 synuclein 
 accumulation 
 neuroinﬂammation 
 oxidative 
 stress 
 mitochondrial 
 dysfunction 
 
 excessive 
 consumption 
 
 neuromelanin 
 
 
 possible 
 trigger 
 
 in-depth 
 research suggest insulin resistance crucial 
 factor pd development disease progression dai et al. 2023 
 study brain rat model pd reveal 
 signiﬁcantly 
 decrease 
 insulin 
 level 
 
 insulin 
 resistance 
 researcher antidiabetic drug improve 
 health status patient pd highlight 
 importance alleviate insulin signaling pathway 
 disease Bassil et al. 2022 Kakoty et al. 2023b researcher 
 
 apply 
 mathematical 
 modeling 
 
 elucidate 
 insulin 
 resistance brain patient pd result 
 demonstrate insulin resistance develop gradually 
 disease severity insulin resistance marker present 
 striatum furthermore study suggest insulin resistance 
 signiﬁcantly increase Morris et al. 2011 Braatz Coleman 
 2015 high-fat diet ultimately induce behavioral change 
 disease exacerbation rat Morris et al. 2010 Sharma taliyan 
 2018 insulin level peripheral plasma observe 
 signiﬁcantly low patient pd healthy 
 individual sánchez-gómez et al. 2020 possibly explain 
 prevalence insulin resistance brain blood 
 circulation patient pd contrast patient new- 
 onset pd exhibit insulin resistance-related feature Aziz 
 et al. 2020 patient diabete likely 
 develop pd potentially mitochondrial function elevated 
 oxidative stress level cause insulin resistance additionally 
 extensive loss dopaminergic neuron exacerbate memory 
 impairment Fiory et al. 2019 example pd-like change 
 observe insulin-resistant ped/pea-15 transgenic mouse 
 model mouse 26 reduction dopamine ﬁber 
 48 decline dopamine level detect striatum 
 Perruolo 
 et 
 al. 
 2016 
 
 conﬁrming 
 
 destructive 
 relationship pd insulin resistance intranasal insulin 
 intervention pd rat model observe improve cognitive 
 ability insulin activation akt/gsk3β signaling pathway 
 figure 2 
 molecular mechanism insulin resistance neurodegenerative disease insulin resistance aggravate ad development inhibit pi3k/ 
 akt/gsk3β pathway induce tau protein hyperphosphorylation additionally insulin resistance impede wnt signaling pathway exacerbate 
 Aβ deposition mechanism escalate occurrence insulin resistance b insulin resistance activate starvation glial cell 
 microglia induce apoptosis lower proportion neuron worsen pd progression c hd cause gca sequence duplication lead 
 insulin resistance regulation Socrs1 Hh-II Vldlr hd ampliﬁes disease progression d increase free fatty acid ffa level 
 patient als induce insulin resistance turn lead decrease ir irs-1/β expression e insulin resistance increase cognitive 
 decline patient ms ad Alzheimer disease pd Parkinson disease hd Huntington disease als amyotrophic lateral sclerosis Aβ 
 amyloid beta 
 Frontiers Physiology 
 frontiersin.org 
 05 
 Shen et al. 
 10.3389/fphys.2024.1337442 
 Figure 2b Yang et al. 2020 animal experiment 
 demonstrate insulin-stimulating peptide d-ala2-gip-glu- 
 pal increase insulin secretion reduce insulin resistance 
 change lead change include improve slow 
 movement balance ability mouse increase exploration 
 ability pd mouse decrease astrocyte microglia proportion 
 substantia nigra enhance number neuronal synapsis 
 lower neuronal apoptosis increase population tyrosine 
 hydroxylase-positive dopaminergic neuron substantia nigra 
 increase striatal tyrosine hydroxylase level Li et al. 2016 
 conversely high-fat diet severely escalate insulin resistance 
 mouse α-synuclein gene mutation rodriguez-araujo et al. 
 2015 series study indicate high-fat diet 
 induce exacerbate dopaminergic degeneration Bousquet et al. 
 2012 individual metabolic syndrome observe 
 exhibit signiﬁcantly increase pd risk Park et al. 2021 
 ﬁnding imply insulin resistance 
 important factor trigger complicate pd 
 insulin resistance pd brain closely related metabolic 
 disease underlie relationship pd insulin 
 resistance remain unknown nonetheless amelioration 
 relevant 
 metabolic 
 disease 
 
 insulin 
 resistance 
 
 
 essential prevention management pd 
 4.3 Insulin resistance Huntington 
 disease hd 
 hd progressive neurodegenerative disease primarily 
 affect middle-aged elderly adult major cause hd 
 unstable expansion cag repeat autosomal chromosome 
 4 convert disease-speciﬁc huntingtin protein htt 
 mutate huntingtin protein mhtt subsequent accumulation 
 mutate protein brain ampliﬁes decline neuronal 
 function ultimately lead disease occurrence dominant 
 genetic pattern bate et al. 2015 hd know 
 Huntington chorea behavioral change manifest 
 involuntary movement small trunk face muscle 
 abnormal muscle tone hyperreﬂexia advancement 
 hd result cognitive decline follow difﬁcultie 
 swallowing speak ultimately death 
 study transgenic mouse r6/2 hd model determine 
 expand cag repeat sequence hd gene lead 
 signiﬁcant reduction glucagon insulin level 
 pancreatic 
 tissue 
 
 
 α- 
 
 β-cell 
 respectively 
 correspondingly study reveal decrease 
 glucagon insulin level patient diabete 
 10 15 respectively compare level control 
 group furthermore number cag repeat inversely 
 associate 
 
 insulin 
 sensitivity 
 Hurlbert 
 et 
 al. 
 1999 
 Björkqvist et al. 2006 Aziz et al. 2010 research involve 
 hd transgenic mouse model demonstrate impaired insulin 
 expression 
 production mouse pancreas 
 accompany 
 
 reduce 
 expression 
 
 key 
 insulin 
 gene 
 transcription factor impaired pancreatic function 
 critical factor development diabete 
 mouse model Andreassen et al. 2002 researcher observe 
 restore insulin signaling sirt2 inhibition provide 
 neuronal protection luthi-carter et al. 2010 Arora Dey 
 2016 additionally liquid chromatography-high-resolution mass 
 spectrometry analysis reveal insulin resistance urine r6/ 
 2 mouse speziale et al. 2023 transcriptomic investigation 
 report signiﬁcant change gene involve glucose 
 uptake homeostasis sorcs1 hh-ii Vldlr low 
 glucose uptake rate affect tissue subsequent development 
 insulin resistance chave et al. 2017 Figure 2C metformin 
 administration report extend lifespan hd 
 mouse model 20 ma et al. 2007 signify 
 relationship 
 
 insulin 
 resistance 
 
 
 diabetes- 
 inducing factor hd examination normoglycemic patient 
 hd reveal abnormal blood glucose regulation 
 delay insulin peak oral glucose tolerance test ogtts 
 decrease insulin secretion level Lalić et al. 2008 Russo et al. 
 2013 contrast ﬁnding study indicate 
 patient hd exhibit increase risk diabete 
 signiﬁcant difference related metabolic indicator histological 
 manifestation insulin secretion level observe baco 
 et al. 2008 Boesgaard et al. 2009 Nambron et al. 2016 
 study primarily suggest insulin 
 resistance manifest hd alleviate insulin 
 resistance 
 
 mitigate 
 hd 
 progression 
 
 hd 
 progression related mhtt-induced inhibition 
 pancreatic cell function reduction insulin sensitivity 
 InsRs body cell insulin resistance patient 
 hd outcome hd progression insulin 
 resistance turn worsen disease course patient health 
 improve insulin resistance provide feasible 
 approach reduce adverse effect hd progression 
 4.4 Insulin resistance amyotrophic 
 lateral sclerosis als 
 als degenerative neurological disease mainly cause 
 degradation loss central nervous system motor 
 neuron control skeletal muscle eventually lead 
 skeletal muscle atrophy death failure swallow 
 breathing 
 Insulin resistance detect patient als early 
 1984 defective insr function emergence 
 receptor antagonist represent speciﬁc underlie mechanism 
 remain unclear Reyes et al. 1984 study conduct 
 year demonstrate contrast ﬁnding sign 
 differential deterioration glucose tolerance detect 
 patient als compare healthy individual evidence 
 (125i)-insulin binding ogtt result Harno et al. 
 1984 conversely study reveal patient als 
 exhibit abnormal glucose tolerance increase concentration 
 free fatty acid important inducer insulin resistance 
 Pradat et al. 2010 subsequent study conﬁrme insulin 
 resistance patient als associate reduce insr 
 expression figure 2d Perurena Festoff 1987 postmortem 
 study reveal insr irs-1/β expression signiﬁcantly 
 reduce muscle ﬁbroblast patient spinal cord 
 bulbar muscular atrophy insulin resistance critical 
 indicator disease severity Nakatsuji et al. 2017 furthermore 
 Frontiers Physiology 
 frontiersin.org 
 06 
 Shen et al. 
 10.3389/fphys.2024.1337442 
 presence hypermetabolic disease determine 
 common characteristic patient als disease 
 onset diagnosis Tsai et al. 2019 researcher 
 suggest 
 
 alternative 
 
 potentially 
 
 reasonable 
 explanation insulin resistance patient als 
 closely link limitation perform daily activity 
 disease severity Harris et al. 1986 certain study 
 propose insulin resistance-induced metabolic difference 
 exacerbate skeletal muscle atrophy disease 
 course de la Rubia Ortí et al. 2021 finally skeletal muscle atrophy 
 early impairment insulin secretion lead hyperosmolar 
 hyperglycemia patient late-stage als Shimizu et al. 2011 
 consider ﬁnding insulin resistance occur als 
 essential factor inducing exacerbate 
 disease predict incidence actively 
 focus insulin resistance prove valuable prevention 
 treatment als 
 4.5 Insulin resistance multiple 
 sclerosis ms 
 ms debilitating disorder central nervous system 
 unknown etiology ms attribute genetic 
 environmental factor induce neuroinﬂammation ultimately 
 cause damage degeneration brain spinal cord 
 major symptom ms include limb numbness abnormality 
 vision cognition speech death 
 metabolomic study blood sample 64 patient 
 ms 33 patient exhibit insulin resistance base Quantose 
 score ruiz-argüelle et al. 2018 study establish 
 insulin resistance metabolic syndrome common 
 patient ms normal individual Soliman 
 et al. 2020 support previous ﬁnding improve metabolic 
 syndrome find play positive role prevent 
 treating ms Haghikia Gold 2016 contrast ogtt 
 result 
 indicate 
 
 decrease 
 insulin 
 sensitivity 
 
 
 postprandial hyperinsulinemia directly related 
 lack exercise high inﬂammation level penesova et al. 
 2015 study demonstrate patient 
 ms diabete present insulin resistance 
 signiﬁcant reduction insulin secretion Katsuki et al. 1998 
 Kouchaki et al. 2017 researcher demonstrate 
 insulin resistance associate cognitive decline patient 
 ms cognitive decline rate 67.56 patient 
 concurrent ms insulin resistance Khalili et al. 2020 
 Ayromlou et al. 2023 furthermore onset ir 
 precede blood lipid change early stage ms Radikova 
 et al. 2018 additionally 12 week high-intensity aerobic 
 resistance training improve glucose tolerance patient ms 
 10 week aerobic exercise training reduce insulin 
 resistance woman ms Sadegh Golestany 2017 
 Wens et al. 2017 conversely certain study demonstrate 
 glucose control patient ms enhance 
 24 week combined endurance resistance training Wens 
 et al. 2015 prevalence type ii diabete mellitus 
 t2dm ms population < 10 rate high 
 general population Giannopapas et al. 2023 
 patient t2dm ms population display signiﬁcantly 
 reduce level insulin secretion compare patient 
 t2dm Katsuki et al. 1998 observe 
 previously 
 mention 
 neurodegenerative 
 disease 
 intranasal 
 insulin intervention signiﬁcantly augment cognitive ability 
 patient ms provide supportive evidence 
 mechanism insulin resistance patient ms Mowry 
 et al. 2017 base result insulin resistance exist 
 ms ameliorate attenuate ms progression serve 
 useful 
 strategy 
 
 
 prevention 
 
 management 
 
 ms figure 2e 
 5 Exercise reduce insulin resistance 
 improve neurological disease 
 limited study show exercise effectively reduce 
 central 
 
 peripheral 
 insulin 
 resistance 
 
 improve 
 neurodegenerative disease study 
 focus ad pd ms disease model population 
 relevant research find 6 week swimming 
 resistance exercise d-galactose-induced ad-like model 
 increase circulate insulin-like growth factor 1 igf-1 level 
 body lead improvement cognitive ability Özbeyli 
 et al. 2017 ad rat model induce exogenous 
 Streptozotocin 
 stz 
 
 Aβ 
 injection 
 treadmill 
 exercise 
 signiﬁcantly activate insulin signaling pathway 
 hippocampus 
 reduce 
 peripheral 
 blood 
 glucose 
 level 
 
 improve cognitive ability Kang Cho 2014 Farokhi Larijani 
 et al. 2023 notably change appear transgenic ad 
 mouse um et al. 2008 Kim et al. 2022 16-week study 
 patient ad aerobic exercise result decrease blood 
 glucose level improve insulin resistance 24- 
 week intervention patient ad decrease insulin 
 resistance observe reason difference result 
 related difference intervention duration sample 
 size study previous study show 
 exercise partially suppress insulin resistance ad model 
 human human study require large sample 
 size in-depth investigation 
 study show aerobic exercise lower- 
 intensity balance exercise effective reduce insulin 
 resistance igf-1 level pd population Szymura et al. 
 2020 soke et al. 2021 combine aerobic strength 
 exercise multi-modal exercise demonstrate 
 signiﬁcantly reduce fast blood glucose level increase igf-1 
 level 
 
 cognitive 
 ability 
 Krumpolec 
 et 
 al. 
 2017 
 Stuckenschneider et al. 2021 mixed exercise model 
 appear effective lower blood sugar level 
 improve peripheral insulin resistance individual pd 
 ms model swimming free-wheel exercise activate 
 igf-1/akt/foxo3a igf-1 pi3k/akt signalling 
 pathway 
 
 
 skeletal 
 muscle 
 
 spinal 
 cord 
 tissue 
 respectively Kaspar et al. 2005 Cieminski et al. 2021 exercise 
 patient ms show good anti-insulin resistance effect 
 home exercise swimming aerobic exercise 
 resistance exercise variety combined exercise 
 training program improve glucose tolerance reduce 
 Frontiers Physiology 
 frontiersin.org 
 07 
 Shen et al. 
 10.3389/fphys.2024.1337442 
 blood sugar level insulin resistance varying degree 
 improvement observe patyn 2014 wen et al. 
 2015 Sadegh Golestany 2017 wen et al. 2017 Ispoglou 
 et al. 2023 
 Exercise play positive role neurodegenerative disease 
 improve peripheral central insulin resistance table 1 
 research neurodegenerative disease lack 
 6 potential mechanism exercise 
 improve insulin resistance 
 Exercise long recognize important strategy 
 preventing treat chronic disease accelerate recovery 
 molecular mechanism underlie beneﬁcial 
 effect exercise require systematic exploration 
 involve broad concept motion consider insulin 
 resistance establish occur neurodegenerative 
 disease 
 exercise 
 
 represent 
 
 feasible 
 intervention 
 
 improve 
 insulin 
 resistance 
 
 
 molecular 
 mechanism 
 potentially 
 involve 
 mitochondrial 
 quality 
 inﬂammation 
 autophagy endoplasmic reticulum stress reactive oxygen 
 specie summarize trigger factor 
 exercise 
 reverse 
 insulin 
 resistance 
 
 provide 
 possible 
 mechanism exercise reverse insulin resistance 
 neurodegenerative disease 
 6.1 Mitochondria quality 
 Mitochondria pivotal organelle involve cellular energy 
 metabolism abundant tissue strong energy 
 demand mitochondria primarily generate atp oxidative 
 phosphorylation pathway regular physiological function 
 insulin/irs/glut4 pathway main route cell 
 glucose convert energy mitochondrial processing 
 mitochondrial oxidative phosphorylation theoretically 
 follow insulin-mediated glucose uptake high-glucose-induced 
 insulin 
 model 
 
 primary 
 cortical 
 neuron 
 indicate 
 
 mitochondrial 
 dysfunction 
 
 
 associate 
 
 insulin 
 resistance Peng et al. 2016 ultimately lead acute insulin 
 resistance mouse Lee et al. 2021 example knockout 
 mitophagy-related protein fndc1 increase susceptibility 
 obesity-induced insulin resistance wu et al. 2019 
 study demonstrate mitochondrial dysfunction 
 crucial component development ir hoek 
 Schrauwen 2012 furthermore skeletal muscle insulin resistance 
 signiﬁcantly reduce transient transfection 
 mitochondrial 
 quality regulatory protein pgc-1α known 
 regulator mitochondrial quantity respiration Benton 
 et al. 2008 pagel-langenickel et al. 2008 contrast skeletal 
 muscle study indicate insulin resistance 
 consequence decrease mitochondrial number 
 mitochondrial function vital action insulin insulin 
 resistance arise mitochondrial electron transport 
 chain disrupt Han et al. 2011 Holloszy 2013 insulin 
 resistance lead deterioration mitochondrial function 
 quality alteration improve insulin treatment 
 mitochondrial proteome potential mechanism 
 Zabielski et al. 2016 mitochondrial dysfunction 
 presence insulin resistance elevate level reactive oxygen 
 specie ros create vicious cycle aggravate 
 insulin resistance figure 3a ruegsegger et al. 2018 Ayer et al. 
 2022 physical activity consider dominant player link 
 insulin resistance mitochondrial respiration 
 imply regulate monitor aerobic capacity 
 critical manage mitochondrial respiration-induced 
 insulin resistance Dela Helge 2013 relationship 
 mitochondria insulin complex in-depth research 
 examine relevant molecular mechanism beneﬁcial 
 reduce insulin resistance regulate mitochondria conversely 
 study demonstrate improve mitochondrial 
 proportion respiratory function exercise 
 alleviate insulin resistance individual obesity hey- 
 Mogensen et al. 2010 
 speciﬁc difference exist glucose uptake 
 nervous system peripheral tissue exercise ameliorate 
 mitochondrial damage Park et al. 2018 enhance mitochondrial 
 function ruegsegger et al. 2019 reduce ros level Ayer et al. 
 2022 regulate mrna translation 
 comprehensive 
 beneﬁcial effect exercise Jannig Ruas 2017 suggest 
 potential crucial approach improve insulin resistance 
 targeting 
 mitochondrial 
 quality 
 
 ultimately 
 mitigating 
 neurodegenerative disease 
 6.2 Inﬂammation 
 Inﬂammation induce aggravate numerous disease 
 study highlight important promoter 
 insulin resistance inﬂammation-induced insulin resistance 
 nervous system predominantly occur increase level 
 inﬂammatory factor ros endoplasmic reticulum stress 
 tnf-α/tnfr1 pkc lps/tlrs activation intracellular jnk 
 ikkβ/nf-κb. inﬂammatory cascade inhibit irs- 
 1 
 ultimately 
 lead 
 
 insulin 
 resistance 
 
 
 inﬂammatory pathway inﬂammation induce microglial 
 activation establish critical component 
 inducing insulin resistance doust et al. 2022 study 
 demonstrate inhibit microglial activation restore 
 insulin resistance-related cognitive decline Chunchai et al. 
 2018 presence absence component 
 inﬂammatory cascade improve insulin resistance 
 example lps-induced inﬂammation key tool animal 
 cellular modelling neuroinﬂammation lps suggest 
 cause insulin resistance central nervous system affect 
 jnk activation rorato et al. 2017 furthermore tlr4 knockout 
 observe reduce high-fat diet-induced insulin resistance 
 mouse shi et al. 2006 inhibit central ikkβ/nf-κb decrease 
 insulin resistance brain Figure 3b Benzler et al. 2015 
 study demonstrate peripheral inﬂammation- 
 induced central insulin resistance mitigate inhibit 
 inﬂammation central nervous system Milanski et al. 2012 
 Research involve inﬂammation-mediated insulin resistance 
 show close link peripheral disease nervous 
 system study reveal obesity prominent 
 Frontiers Physiology 
 frontiersin.org 
 08 
 Shen et al. 
 10.3389/fphys.2024.1337442 
 chronic inﬂammation promoter body associate 
 signiﬁcantly increase risk develop neurodegenerative disease 
 Spielman et al. 2014 reasonable physical exercise provide 
 valuable mean inhibit inﬂammation microglial activation 
 Wang et al. 2016 conﬁrmatory indicating exercise 
 prevent treat neurological disease inhibit inﬂammation- 
 mediated insulin resistance example study establish 
 swimming lower insulin resistance mouse 
 hippocampus decrease nervous system inﬂammation Zhang 
 H. et al. 2022 resistance exercise training 
 report effectively alleviate neuroinﬂammation mouse 
 brain 
 Kelty 
 et 
 al. 
 2019 
 furthermore 
 exercise-induced 
 suppression inﬂammation yield positive effect 
 context neurodegenerative disease ad pd 
 beneﬁts closely related mitigation insulin 
 resistance Li et al. 2022 Wang et al. 2023 
 inﬂammation-regulated insulin resistance associate 
 mechanism 
 act 
 
 neurodegenerative 
 change 
 
 indicating exercise intervention target reduction 
 inﬂammation level represent useful strategy 
 figure 3 
 potential molecular mechanism exercise improve insulin resistance exercise alleviate insulin resistance improve mitochondrial 
 quality reduce ros b decrease endoplasmic reticulum stress c activate ampk induce autophagy d inhibit microglial activation 
 jnk nf-κb phosphorylation lower neuroinﬂammatory factor e 
 Frontiers Physiology 
 frontiersin.org 
 09 
 Shen et al. 
 10.3389/fphys.2024.1337442 
 6.3 Autophagy 
 Autophagy classical mechanism self-degradation 
 organelle misfolde protein damage aging abnormal 
 autophagy level report disease 
 indicate regulation autophagy potential mechanism 
 prevention treatment numerous disease autophagy 
 encompass autophagy-related protein form circular 
 vesicle speciﬁc sequence engulf component require 
 degradation combine lysosome ultimately lead 
 breakdown component essential substance 
 available recycling excessive activation 
 inhibition autophagy trigger certain disease example 
 certain study link knockout autophagy gene 
 ATG16L1 insulin resistance frendo-cumbo et al. 2019 
 study find reduce miR-188 inhibitor 
 target autophagy-related gene atg12 enhance insulin resistance 
 Liu et al. 2020 additionally impede activation mitophagy 
 sirt1/ampk-pgc1α signaling pathway mir-302 
 human podocyte signiﬁcantly reduce insulin resistance hd 
 Chang et al. 2021 cell experiment human podocyte 
 demonstrate autophagy activation signiﬁcantly alleviate 
 insulin resistance attribute high glucose level xin et al. 2016 
 contrast minimize autophagy induce autophagic ﬂux 
 lead insulin resistance body cai et al. 2018 oh et al. 
 2023 researcher demonstrate regulation 
 table 1 exercise improve insulin resistance neurodegenerative disease 
 Model 
 Exercise model 
 Exercise dose 
 Changes indicator 
 related insulin 
 resistance 
 Source 
 test 
 reference 
 ad patient 
 Aerobic exercise 
 60 min/time 3 times/ 
 week 16 week 
 HDL↑ blood glucose insulin→ 
 Plasma 
 Jensen et al. 2020 
 ad patient 
 Aerobic exercise 
 45–60 min/time 4 times/ 
 week 24 week 
 Insulin sensitivity↑ 
 Plasma 
 Baker et al. 2010 
 ad 3xtg ad mouse 
 Treadmill run 
 13 m/min 50 min/time 
 6 times/week 12 week 
 Insulin signaling↑ 
 Hippocampus 
 Kim et al. 2022 
 ad aβ-induced ad rat 
 Treadmill run 
 60 min/time 7 times/ 
 week 4 week 
 Glucose level↓ cognitive function↑ 
 Plasma 
 Farokhi Larijani et al. 
 2023 
 ad stz-induced ad model 
 Treadmill run 
 14 m/min 30 min/time 
 5 times/week 6 week 
 Insulin signaling pathway 
 cognitive function↑ 
 Hippocampus 
 Kang Cho 2014 
 ad model nse/appsw-tg 
 mouse 
 Treadmill run 
 22 m/min 60 min/time 
 5 times/week 16 week 
 Blood glucose↓ glut1 
 cognitive function↑ 
 Plasma 
 um et al. 2008 
 ad-like model d-galactose 
 induce Wistar rat 
 swimming resistance 
 exercise 
 60 min/time 3 times/ 
 week 6 week 
 igf-i cognitive function↑ 
 plasma brain 
 Özbeyli et al. 2017 
 pd patient 
 Aerobic exercise 
 30 min/time 3 times/ 
 week 8 week 
 igf-1→ 
 Plasma 
 Soke et al. 2021 
 pd patient 
 aerobic-strength training 
 60 min/time 3 times/ 
 week 12 week 
 Fasting 2 h blood glucose↓ 
 Plasma 
 Krumpolec et al. 
 2017 
 pd patient 
 Balance training 
 60 min/time 3 times/ 
 week 12 week 
 igf-1→ 
 Plasma 
 Szymura et al. 2020 
 pd patient 
 Multimodal exercise 
 intervention method 
 60 min/time 2 times/ 
 week 8 week 
 igf-1↑ cognitive function→ 
 Plasma 
 behavior 
 Stuckenschneider 
 et al. 2021 
 ms patient 
 Home exercise 
 2 time/week 24 week 
 igf-1↑ 
 Plasma 
 Ispoglou et al. 2023 
 ms patient 
 Aerobic exercise 
 resistance exercise 
 5 time/2 week 24 week 
 fasting blood glucose tauc 
 ogtt↓ gt GLUT4↑ 
 Plasma 
 Wens et al. 2017 
 ms patient 
 Joint training plan 
 5 time/2 week 24 week 
 fasting blood glucose insulin 
 tAUC→ 
 Plasma 
 Wens et al. 2015 
 ms patient 
 Swimming 
 10 week 
 fasting glucose insulin 
 resistance↓ 
 Plasma 
 Sadegh Golestany 
 2017 
 ms patient 
 resistance high- 
 intensity interval training 
 12 week 
 glucose tolerance↑ 
 Plasma 
 Patyn 2014 
 ms model sod1 transgenic 
 mouse 
 Swimming 
 30 min/time 5 times/ 
 week 6.5 week 
 igf-1/akt/foxo3a↑ 
 Muscle 
 Cieminski et al. 
 2021 
 ms model sod1 transgenic 
 mouse 
 voluntary wheel run 
 6 12 h 
 igf-1 pi3k/akt↑ 
 spinal cord 
 Kaspar et al. 2005 
 tauc total area glucose curve gt glucose tolerance igf-1 insulin-like growth factor 1 glut 1/4 glucose transporter type 1/4 ↑ represent upregulation ↓ represent 
 downregulation → represent change 
 Frontiers Physiology 
 frontiersin.org 
 10 
 Shen et al. 
 10.3389/fphys.2024.1337442 
 autophagy level signiﬁcantly attenuate disease-related insulin 
 resistance ad rat model oh et al. 2023 previous study 
 suggest autophagy disorder defect provide 
 possible explanation exacerbation stress-induced insulin 
 resistance islet cell endoplasmic reticulum zhou et al. 
 2009 Yang et al. 2010 enhance autophagy 
 effectively 
 improve 
 insulin 
 sensitivity 
 
 cognitive 
 defect 
 Wang et al. 2016 exercise consider primary approach 
 activate autophagy pivotal technique consume 
 energy role exercise disease prevention 
 treatment inextricably associate regulation autophagy 
 Sujkowski et al. 2022 support concept study 
 demonstrate exercise initiate autophagy improve 
 insulin sensitivity activate interaction ampk 
 sestrin figure 3c sujkowski et al. 2022 researcher 
 observe exercise reduce manifestation 
 insulin resistance activate autophagy skeletal muscle 
 mouse feed high-fat diet Cheng et al. 2022 study 
 note exercise mitigate insulin resistance stimulate 
 short-chain fatty acid Yang et al. 2020 bcl-2 et al. 2012 
 pathway activate autophagy study link autophagy 
 
 insulin 
 
 neurodegenerative 
 disease 
 remain 
 limited 
 regulation autophagy nervous system cell 
 improve insulin resistance represent potential strategy 
 managing neurodegenerative disease 
 6.4 endoplasmic reticulum stress ers 
 endoplasmic reticulum er critical protein synthesis 
 folding maturation nutrient deﬁciency ca2 + disorder ros 
 
 glycosylation 
 inhibition 
 lead 
 
 increase 
 endoplasmic 
 reticulum misfolde protein trigger endoplasmic reticulum 
 stress turn induce unfolded protein endoplasmic reticulum 
 overload caspase-12-mediate response signal pathway 
 
 
 
 apoptotic 
 pathway 
 furthermore 
 damage 
 
 mitochondria-associated 
 endoplasmic 
 reticulum 
 membrane 
 cause 
 
 endoplasmic 
 reticulum 
 stress 
 
 promote 
 
 development hypothalamic insulin resistance Cheng et al. 
 2020 
 experiment 
 investigate 
 
 effect 
 
 induce 
 endoplasmic 
 reticulum 
 stress 
 
 pomc 
 neuron 
 observe 
 inhibition activation insulin signaling pathway 
 Williams et al. 2014 diabetes-related brain damage 
 improve inhibit endoplasmic reticulum stress Hu et al. 
 2020 researcher reveal genetic deletion 
 endoplasmic reticulum stress-related protein ire1α 
 activate perk-mediated phosphorylation foxo 
 initiate worsen occurrence insulin resistance Zhang 
 et al. 2013 Yao et al. 2017 possible mechanism insulin 
 resistance transfer newly synthesize insrs cell 
 surface endoplasmic reticulum stress Brown et al. 2020 
 similar observation note hippocampal tissue sims- 
 Robinson et al. 2016 inhibit endoplasmic reticulum 
 stress reduce insulin resistance eo valentine 2021 
 furthermore activation endoplasmic reticulum stress 
 perk-eif2α pathway result insulin resistance Li et al. 
 2015 activate atf6 protect insrs 
 endoplasmic 
 reticulum 
 stress-mediated 
 desensitization 
 
 
 certain extent Tang et al. 2011 researcher 
 demonstrate appropriate exercise weaken cellular 
 response endoplasmic reticulum stress Marafon et al. 2022 
 additional study suggest exercise potentially reduce 
 insulin 
 resistance 
 
 cognitive 
 impairment 
 
 improve 
 endoplasmic reticulum stress figure 3d George et al. 2018 
 Exercise 
 regulate 
 endoplasmic 
 reticulum 
 stress 
 improve 
 endoplasmic reticulum stress skeletal muscle improve 
 insulin resistance Cheng et al. 2022 similarly endoplasmic 
 reticulum stress detect liver adipose tissue obese 
 rat improve increase insulin sensitivity exercise da 
 Luz et al. 2011 exercise intervention mitigate insulin 
 resistance neurodegenerative disease intricately link 
 reduction endoplasmic reticulum stress target 
 amelioration endoplasmic reticulum stress insulin resistance 
 require exploration ﬁeld neurodegeneration 
 6.5 reactive oxygen specie ros 
 ros include o₂•- oh h₂o₂ primarily generate 
 mitochondrial oxidative phosphorylation activation 
 mitochondrial permeability transition pore inner membrane 
 anion channel result oxidation 
 mitochondrial membrane ros leakage occur 
 change reduction environment Zorov et al. 2014 
 mutual restriction oxidation antioxidant system 
 essentially maintain normal intracellular ros level moderate 
 concentration ros require normal intracellular 
 signaling excessive ros level induce inﬂammation 
 endoplasmic reticulum stress dna damage participate 
 molecular signaling pathway damage body environment 
 trigger related disease insulin resistance detrimental 
 effect cause alter ros level ros inhibit binding 
 irs-1/2 insr activate jnk p38 mapk ikkβ PKCθ 
 inhibiting ptp1b PTEN Tiganis 2011 current research 
 demonstrate exercise induce short-term increase ros 
 level alteration cause insulin resistance 
 exercise reduce ros level observation 
 exercise intensity closely related reasonable long-term exercise 
 improve antioxidant system body manage oxidative 
 stress figure 3e Nocella et al. 2019 study 
 conduct examine role exercise context 
 regulate ros level reduce insulin resistance alleviate 
 neurodegenerative disease change ros level represent 
 theoretically feasible mechanism explain applicability 
 exercise 
 
 
 prevention 
 
 treatment 
 
 chronic 
 neurodegenerative disease 
 7 Conclusion 
 Insulin resistance abnormal energy metabolic process 
 impair nutrient-absorbing ability cell ultimately result 
 abnormal physiological function body insulin resistance 
 crucial factor promote exacerbate neurodegenerative 
 disease review discuss insulin resistance 
 context prominent neurodegenerative disease Alzheimer 
 Frontiers Physiology 
 frontiersin.org 
 11 
 Shen et al. 
 10.3389/fphys.2024.1337442 
 disease Parkinson disease Huntington disease Amyotrophic 
 Lateral Sclerosis Multiple Sclerosis summarize 
 potential molecular mechanism regulate exercise-associated 
 insulin resistance neurodegenerative disease contribute 
 improvement alleviation disorder 
 exercise 
 intervention 
 
 
 challenge 
 
 
 neurodegenerative 
 disease 
 
 progress 
 rapidly 
 moderate 
 exercise early stage disease extend 
 treatment 
 period 
 
 alleviate 
 disease 
 progression 
 
 improve insulin resistance exercise represent valuable 
 
 essential 
 intervention 
 Exercise 
 
 ameliorate 
 neurodegenerative disorder regulate mitochondrial quality 
 inﬂammation autophagy endoplasmic reticulum stress ros 
 production study investigate relationship 
 neurodegenerative disorder exercise insulin resistance 
 limited 
 
 
 in-depth 
 exploratory 
 research 
 
 require aspect help provide future 
 direction prevent treat insulin resistance 
 neurodegenerative disease exercise 
 Author contribution 
 hz 
 Funding 
 acquisition 
 writing original 
 draft 
 writing review 
 
 editing 
 JS 
 writing original 
 draft 
 writing review editing xw write original draft mw 
 Conceptualization writing review editing 
 Funding 
 author(s declare ﬁnancial support receive 
 research authorship and/or publication article 
 acknowledgment 
 thank Bullet Edits Limited linguistic editing 
 proofreading manuscript 
 Conﬂict interest 
 author declare research conduct 
 absence commercial ﬁnancial relationship 
 construe potential conﬂict interest 
 Publisher note 
 claim express article solely author 
 
 
 
 necessarily 
 represent 
 
 
 
 afﬁliated 
 organization publisher editor 
 reviewer product evaluate article 
 claim manufacturer guarantee 
 endorse publisher 
 reference 
 Abbasi F. Robakis T. K. Myoraku A. Watson K. T. Wroolie T. Rasgon N. L. 
 2023 insulin resistance accelerate cognitive aging psychoneuroendocrinology 
 147 105944 doi:10.1016/j.psyneuen.2022.105944 
 Abbott M. a. Wells D. G. Fallon J. R. 1999 insulin receptor tyrosine 
 kinase substrate p58/53 insulin receptor component cns synapsis 
 J. Neurosci 19 7300–7308 doi:10.1523/jneurosci.19 17 07300.1999 
 Agrawal M. Saraf S. Saraf S. Antimisiaris S. G. Chougule M. B. Shoyele S. a. 
 et al. 2018 nose-to-brain drug delivery update clinical challenge progress 
 approval anti-alzheimer drug J. Control Release 281 139–177 doi:10.1016/ 
 j.jconrel.2018.05.011 
 Andreassen O. a. Dedeoglu a. Stanojevic V. Hughes D. B. Browne S. E. Leech 
 C. a. et al. 2002 huntington disease endocrine pancreas insulin deﬁciency 
 diabete mellitus impaired insulin gene expression neurobiol dis 11 
 410–424 doi:10.1006/nbdi.2002.0562 
 Angulo J. El Assar M. álvarez-bustos a. Rodríguez-Mañas L. 2020 physical 
 activity exercise strategy manage frailty redox Biol 35 101513 doi:10.1016/j 
 redox.2020.101513 
 Arnold S. E. Arvanitakis Z. Macauley-Rambach S. L. Koenig A. M. Wang H. Y. 
 Ahima R. S. et al. 2018 brain insulin resistance type 2 diabete alzheimer disease 
 concept conundrum nat Rev. Neurol 14 168–181 doi:10.1038/nrneurol.2017.185 
 Arora a. Dey C. S. 2016 sirt2 regulate insulin sensitivity insulin resistant 
 neuronal cell biochem Biophys res commun 474 747–752 doi:10.1016/j.bbrc.2016 
 05.029 
 Athauda D. Foltynie T. 2016 insulin resistance Parkinson disease new 
 target disease modiﬁcation prog neurobiol 145 146 98–120 doi:10.1016/j 
 pneurobio.2016.10.001 
 Ayer A. Fazakerley D. J. James D. E. Stocker R. 2022 role 
 mitochondrial reactive oxygen specie insulin resistance free Radic biol med 
 179 339–362 doi:10.1016/j.freeradbiomed.2021.11.007 
 Ayromlou H. Hosseini S. Khalili M. Ayromlou S. Khamudchiyan S. Farajdokht F. 
 et al. 2023 insulin resistance associate cognitive dysfunction multiple sclerosis 
 patient cross-sectional study J. Neuroendocrinol 35 e13288 doi:10.1111/jne.13288 
 Aziz N. a. Pijl H. Frölich M. Snel M. Streeﬂand T. C. Roelfsema F. et al. 2010 
 systemic energy homeostasis Huntington disease patient J. Neurol Neurosurg 
 Psychiatry 81 1233–1237 doi:10.1136/jnnp.2009.191833 
 Aziz N. a. Roos R. a. C. Pijl H. 2020 insulin sensitivity de novo 
 Parkinson disease hyperinsulinemic-euglycemic clamp study mov disord 35 
 1693–1694 doi:10.1002/mds.28181 
 Bacos K. björkqvist M. Petersén a. lut L. Maat-Schieman M. L. Roos R. a. 
 et al. 2008 islet beta-cell area hormone expression unaltered Huntington 
 disease histochem cell Biol 129 623–629 doi:10.1007/s00418 008 0393-z 
 Baker L. D. Frank L. L. Foster-Schubert K. Green P. S. Wilkinson C. W. 
 McTiernan a. et al. 2010 aerobic exercise improve cognition old adult 
 glucose intolerance risk factor alzheimer disease J. Alzheimers Dis 22 569–579 
 doi:10.3233/jad-2010 100768 
 Banks W. a. Jaspan J. B. Huang W. Kastin A. J. 1997 transport insulin 
 blood-brain barrier saturability euglycemic dose insulin peptide 18 
 1423–1429 doi:10.1016/s0196 9781(97)00231 3 
 Bassil F. Delamarre a. Canron M. H. Dutheil N. Vital a. négrier-leibreich M. 
 L. et al. 2022 impaired brain insulin signalling Parkinson disease neuropathol 
 appl neurobiol 48 e12760 doi:10.1111/nan.12760 
 Bates G. P. Dorsey R. Gusella J. F. Hayden M. R. Kay C. Leavitt B. R. et al. 
 2015 huntington disease nat Rev. Dis prim 1 15005 doi:10.1038/nrdp.2015.5 
 Baura G. D. Foster D. M. Porte D. Jr. Kahn S. E. Bergman R. N. Cobelli C. et al. 
 1993 saturable transport insulin plasma central nervous system 
 dog vivo mechanism regulate insulin delivery brain J. Clin invest 92 
 1824–1830 doi:10.1172/jci116773 
 Benedict C. Brooks S. J. Kullberg J. Burgos J. Kempton M. J. Nordenskjöld R. 
 et al. 2012 impaired insulin sensitivity index homa score associate 
 deﬁcit verbal ﬂuency temporal lobe gray matter volume elderly 
 Diabetes Care 35 488–494 doi:10.2337/dc11 2075 
 Benton C. R. Nickerson J. G. lally J. Han X. X. Holloway G. P. Glatz J. F. et al. 
 2008 modest pgc-1alpha overexpression muscle vivo sufﬁcient increase 
 insulin sensitivity palmitate oxidation subsarcolemmal intermyoﬁbrillar 
 mitochondria J. Biol Chem 283 4228–4240 doi:10.1074/jbc m704332200 
 Benzler J. Ganjam G. K. Pretz D. Oelkrug R. Koch C. E. Legler K. et al. 2015 
 central inhibition ikkβ/nf-κb signaling attenuate high-fat diet-induced obesity 
 glucose intolerance diabetes 64 2015–2027 doi:10.2337/db14 0093 
 Björkqvist M. Petersén a. Bacos K. Isaacs J. Norlén P. gil J. et al. 2006 
 progressive alteration hypothalamic-pituitary-adrenal axis r6/ 
 Frontiers Physiology 
 frontiersin.org 
 12 
 Shen et al. 
 10.3389/fphys.2024.1337442 
 2 transgenic mouse model Huntington disease hum mol genet 15 1713–1721 
 doi:10.1093/hmg/ddl094 
 Bockmann J. Kreutz M. R. Gundelﬁnger E. D. böcker T. M. 2002 prosap/ 
 shank postsynaptic density protein interact insulin receptor tyrosine kinase 
 substrate irsp53 J. Neurochem 83 1013–1017 doi:10.1046/j.1471 4159.2002.01204.x 
 Boesgaard T. W. Nielsen T. T. Josefsen K. Hansen T. Jørgensen T. Pedersen O. 
 et al. 2009 huntington disease appear increase risk diabete 
 mellitus J. Neuroendocrinol 21 770–776 doi:10.1111/j.1365 2826.2009.01898.x 
 Bomﬁm T. R. Forny-Germano L. sathler L. B. Brito-Moreira J. Houzel J. C. 
 Decker H. et al. 2012 anti-diabete agent protect mouse brain defective 
 insulin signaling cause alzheimer disease-associated aβ oligomer J. Clin invest 
 122 1339–1353 doi:10.1172/jci57256 
 Borai a. Livingstone C. Kaddam I. fern G. 2011 selection 
 appropriate method assessment insulin resistance bmc med res 
 Methodol 11 158 doi:10.1186/1471 2288 11 158 
 Bousquet M. st-amour I. Vandal M. Julien P. Cicchetti F. Calon F. 2012 
 high-fat diet exacerbate mptp-induced dopaminergic degeneration mouse 
 Neurobiol dis 45 529–538 doi:10.1016/j.nbd.2011.09.009 
 Braatz E. M. Coleman R. a. 2015 mathematical model insulin resistance 
 Parkinson disease comput biol Chem 56 84–97 doi:10.1016/j.compbiolchem 
 2015.04.003 
 Brown M. Dainty S. Strudwick N. Mihai A. D. Watson J. N. Dendooven R. et al. 
 2020 endoplasmic reticulum stress cause insulin resistance inhibit delivery 
 newly synthesize insulin receptor cell surface mol biol cell 31 2597–2629 
 doi:10.1091/mbc e18 01 0013 
 Brüning J. C. Gautam D. Burks D. J. Gillette J. Schubert M. Orban P. C. et al. 
 2000 role brain insulin receptor control body weight reproduction 
 science 289 2122–2125 doi:10.1126/science.289.5487.2122 
 Cai J. Pires K. M. Ferhat M. Chaurasia B. Buffolo M. a. smalling R. et al. 2018 
 Autophagy ablation adipocyte induce insulin resistance reveal role lipid 
 peroxide nrf2 signaling adipose-liver crosstalk cell Rep. 25 1708–1717 doi:10 
 1016/j.celrep.2018.10.040 
 Cai Z. Xiao M. Chang L. Yan L. J. 2015 role insulin resistance 
 Alzheimer disease metab Brain Dis 30 839–851 doi:10.1007/s11011 014 9631 3 
 Chang C. C. Tsou S. H. Chen W. J. Ho Y. J. Hung H. C. Liu G. Y. et al. 2021 
 mir-302 attenuate mutant huntingtin-induced cytotoxicity restoration 
 autophagy insulin sensitivity int J. Mol Sci 22 8424 doi:10.3390/ijms22168424 
 Chaves G. Özel R. E. Rao N. V. Hadiprodjo H. Costa Y. D. Tokuno Z. et al. 
 2017 metabolic transcriptomic analysis Huntington disease model reveal 
 change intracellular glucose level related gene heliyon 3 e00381 doi:10.1016/ 
 j.heliyon.2017.e00381 
 Chen Y. Zhao Y. dai C. L. Liang Z. Run X. Iqbal K. et al. 2014 intranasal 
 insulin restore insulin signaling increase synaptic protein reduce aβ level 
 microglia activation brain 3xtg-ad mouse exp neurol 261 610–619 doi:10 
 1016/j.expneurol.2014.06.004 
 Cheng F. Dun Y. Cheng J. Ripley-Gonzalez J. W. Jiang W. B. et al. 2022 
 Exercise activate autophagy regulate endoplasmic reticulum stress muscle 
 high-fat diet mouse alleviate insulin resistance biochem Biophys res commun 601 
 45–51 doi:10.1016/j.bbrc.2022.02.058 
 Cheng H. Gang X. G. Liu Y. Wang Y. Zhao X. et al. 2020 molecular 
 mechanism underlie mitochondria-associated endoplasmic reticulum membrane-induced 
 insulin resistance endocrinol Lausanne 11 592129 doi:10.3389/fendo.2020.592129 
 Chunchai T. thunapong W. Yasom S. Wanchai K. Eaimworawuthikul S. 
 Metzler G. et al. 2018 decrease microglial activation gut-brain axis 
 prebiotic probiotic synbiotic effectively restore cognitive function obese- 
 insulin resistant rat J. Neuroinﬂammation 15 11 doi:10.1186/s12974 018 1055 2 
 Cieminski K. Flis D. J. Dzik K. Kaczor J. J. Czyrko E. Halon-Golabek M. et al. 2021 
 Swim training affect Akt signaling ameliorate loss skeletal muscle mass mouse 
 model amyotrophic lateral sclerosis sci Rep. 11 20899 doi:10.1038/s41598 021 00319 1 
 Cordeiro L. M. Machado M. L. da Silva A. F. Obetine Baptista F. B. da Silveira T. 
 L. Soares F. a. a. et al. 2020 rutin protect huntington disease insulin/ 
 igf1 iis signaling pathway autophagy activity study caenorhabditis elegans 
 model food Chem toxicol 141 111323 doi:10.1016/j.fct.2020.111323 
 Cui Y. Tang T. Y. Lu C. Q. Ju S. 2022 insulin resistance cognitive 
 impairment evidence neuroimaging J. Magn Reson Imaging 56 1621–1649 
 doi:10.1002/jmri.28358 
 Cuperfain A. B. Kennedy J. L. gonçalve V. F. 2020 overlap mechanism 
 link insulin resistance cognition neuroprogression bipolar disorder 
 Neurosci Biobehav Rev. 111 125–134 doi:10.1016/j.neubiorev.2020.01.022 
 Dai C. Tan C. Zhao L. Liang Y. Liu G. Liu H. et al. 2023 glucose metabolism 
 impairment Parkinson disease brain res bull 199 110672 doi:10.1016/j 
 brainresbull.2023.110672 
 da Luz G. Frederico M. J. da Silva S. Vitto M. F. Cesconetto P. a. de Pinho R. a. 
 et al. 2011 endurance exercise training ameliorate insulin resistance reticulum 
 stress adipose hepatic tissue obese rat eur J. appl physiol 111 2015–2023 
 doi:10.1007/s00421 010 1802 2 
 Dela F. Helge J. W. 2013 insulin resistance mitochondrial function 
 skeletal muscle int J. Biochem cell Biol 45 11–15 doi:10.1016/j.biocel.2012.09.019 
 de la Rubia Ortí J. E. Armero J. L. P. Sanchis-Sanchis C. E. sancho-castillo S. 
 Salazar a. Caplliure-Llopis J. et al. 2021 muscle function difference 
 patient bulbar spinal onset amyotrophic lateral sclerosis depend 
 peripheral glucose J. Clin med 10 1582 doi:10.3390/jcm10081582 
 Denver P. English a. McClean P. L. 2018 inﬂammation insulin signaling 
 cognitive function aged app/ps1 mouse brain Behav immun 70 423–434 
 doi:10.1016/j.bbi.2018.03.032 
 Doble B. W. Woodgett J. R. 2003 gsk-3 trick trade multi-tasking 
 kinase J. Cell Sci 116 1175–1186 doi:10.1242/jcs.00384 
 Dorsey E. R. Sherer T. Okun M. S. Bloem B. R. 2018 emerge evidence 
 Parkinson pandemic J. Park dis 8 s3–s8 doi:10.3233/jpd-181474 
 Dou J. T. Chen M. Dufour F. Alkon D. L. Zhao W. Q. 2005 insulin 
 receptor signaling long-term memory consolidation follow spatial learning Learn 
 Mem 12 646–655 doi:10.1101/lm.88005 
 Doust Y. V. Sumargo N. Ziebell J. M. Premilovac D. 2022 insulin resistance 
 brain evidence support role inﬂammation reactive microglia 
 impact biological sex neuroendocrinology 112 1027–1038 doi:10.1159/000524059 
 Emmanuel Y. Cochlin L. E. Tyler D. J. de Jager C. a. Smith A. D. Clarke K. 
 2013 human hippocampal energy metabolism impaired cognitive activity 
 lipid infusion model insulin resistance brain Behav 3 134–144 doi:10.1002/ 
 brb3.124 
 Eo H. Valentine R. J. 2021 imoxin inhibit tunicamycin-induced endoplasmic 
 reticulum stress restore insulin signaling c2c12 myotube J. Physiol cell 
 Physiol 321 c221–c229 doi:10.1152/ajpcell.00544.2020 
 Evans J. L. Maddux B. a. Goldﬁne I. D. 2005 molecular basis 
 oxidative stress-induced insulin resistance Antioxid redox signal 7 1040–1052 doi:10 
 1089/ars.2005.7.1040 
 Fakih W. Zeitoun R. AlZaim I. Eid A. H. Kobeissy F. Abd-Elrahman K. S. et al. 
 2022 early metabolic impairment contributor neurodegenerative disease 
 mechanism potential pharmacological intervention obe Silver Spring 30 
 982–993 doi:10.1002/oby.23400 
 Farokhi Larijani S. Hassanzadeh G. Zahmatkesh M. radfar F. Farahmandfar 
 M. 2023 intranasal insulin intake exercise improve memory function amyloid- 
 β induce alzheimer’s-like disease rat involvement hippocampal bdnf-trkb 
 receptor Behav brain res 460 114814 doi:10.1016/j.bbr.2023.114814 
 Fernandez A. M. Torres-Alemán I. 2012 face insulin-like 
 peptide signalling brain nat Rev. Neurosci 13 225–239 doi:10.1038/nrn3209 
 Fiory F. Perruolo G. Cimmino I. Cabaro S. Pignalosa F. C. Miele C. et al. 2019 
 relevance insulin action dopaminergic system Neurosci 13 868 
 doi:10.3389/fnins.2019.00868 
 Frank S. Testa C. M. Stamler D. Kayson E. Davis C. Edmondson M. C. et al. 
 2016 effect deutetrabenazine chorea patient huntington disease 
 randomized clinical trial jama 316 40–50 doi:10.1001/jama.2016.8655 
 Frendo-Cumbo S. Jaldin-Fincati J. R. Coyaud E. Laurent E. M. N. Townsend L. 
 K. Tan J. M. J. et al. 2019 deﬁciency autophagy gene atg16l1 induce 
 insulin resistance klhl9/klhl13/cul3-mediated irs1 degradation J. Biol 
 Chem 294 16172–16185 doi:10.1074/jbc ra119.009110 
 Gasparini L. Gouras G. K. Wang R. Gross R. S. Beal M. F. Greengard P. et al. 
 2001 stimulation beta-amyloid precursor protein trafﬁcking insulin reduce 
 intraneuronal beta-amyloid require mitogen-activated protein kinase signaling 
 J. Neurosci 21 2561–2570 doi:10.1523/jneurosci.21 08 02561.2001 
 Gasparini L. Netzer W. J. Greengard P. Xu H. 2002 insulin 
 dysfunction play role Alzheimer disease trend Pharmacol Sci 23 288–293 
 doi:10.1016/s0165 6147(02)02037 0 
 George a. K. Behera J. Kelly K. E. Mondal N. K. Richardson K. P. Tyagi N. 
 2018 exercise mitigate alcohol induce endoplasmic reticulum stress mediate 
 cognitive impairment atf6-herp signaling sci Rep. 8 5158 doi:10.1038/ 
 s41598 018 23568-z 
 Giannopapas V. Palaiodimou L. Kitsos D. Papagiannopoulou G. Stavrogianni K. 
 Chasiotis a. et al. 2023 prevalence diabetes mellitus type ii dmii 
 multiple sclerosis population systematic review meta-analysis J. Clin med 12 
 4948 doi:10.3390/jcm12154948 
 Gustavsson A. Norton N. Fast T. Frölich L. Georges J. Holzapfel D. et al. 2023 
 global estimate number person Alzheimer disease continuum 
 Alzheimers Dement 19 658–670 doi:10.1002/alz.12694 
 Haghikia a. gold R. 2016 positive effect multiple sclerosis treatment 
 metabolic syndrome jama neurol 73 499–501 doi:10.1001/jamaneurol.2015.5050 
 Han D. H. Hancock C. R. Jung S. R. Higashida K. Kim S. H. Holloszy J. O. 
 2011 deﬁciency mitochondrial electron transport chain muscle 
 cause insulin resistance plos 6 e19739 doi:10.1371/journal.pone.0019739 
 Frontiers Physiology 
 frontiersin.org 
 13 
 Shen et al. 
 10.3389/fphys.2024.1337442 
 Harno K. Rissanen a. Palo J. 1984 glucose tolerance amyotrophic lateral 
 sclerosis acta Neurol scand 70 451–455 doi:10.1111/j.1600 0404.1984.tb00851.x 
 Harris M. D. Davidson M. B. Rosenberg C. S. 1986 insulin antagonism 
 primary abnormality amyotrophic lateral sclerois related disease severity 
 J. Clin endocrinol metab 63 41–46 doi:10.1210/jcem-63 1 41 
 Havrankova J. Roth J. Brownstein M. 1978 insulin receptor widely 
 distribute central nervous system rat nature 272 827–829 doi:10.1038/ 
 272827a0 
 C. Bassik M. C. Moresi V. Sun K. Wei Y. Zou Z. et al. 2012 exercise- 
 induce bcl2-regulated autophagy require muscle glucose homeostasis nature 
 481 511–515 doi:10.1038/nature10758 
 Hey-Mogensen M. Højlund K. Vind B. F. Wang L. Dela F. Beck-Nielsen H. 
 et al. 2010 effect physical training mitochondrial respiration reactive 
 oxygen specie release skeletal muscle patient obesity type 2 diabete 
 diabetologia 53 1976–1985 doi:10.1007/s00125 010 1813-x 
 Hoeks J. Schrauwen P. 2012 muscle mitochondria insulin resistance 
 human perspective trend Endocrinol metab 23 444–450 doi:10.1016/j.tem.2012 
 05.007 
 Holliday M. a. 1971 metabolic rate organ size growth infancy 
 maturity late gastation early infancy pediatric 47 Suppl 2 169 
 Holloszy J. O. 2013 deﬁciency mitochondria muscle cause insulin 
 resistance diabete 62 1036–1040 doi:10.2337/db12 1107 
 Hu T. Shi J. J. Fang J. Wang Q. Chen Y. B. Zhang S. J. 2020 quercetin 
 ameliorate diabetic encephalopathy sirt1/er stress pathway db/db mouse 
 aging Albany NY 12 7015–7029 doi:10.18632/aging.103059 
 Hurlbert M. S. Zhou W. Wasmeier C. Kaddis F. G. Hutton J. C. Freed C. R. 
 1999 mouse transgenic expand cag repeat Huntington disease gene 
 develop diabete diabete 48 649–651 doi:10.2337/diabetes.48.3.649 
 Ispoglou T. Ferentinos P. Prokopidis K. Blake C. Aldrich L. Elia a. et al. 2023 
 explore impact exercise essential amino acid plus cholecalciferol 
 supplementation physical ﬁtness body composition multiple sclerosis 
 case study clin case Rep. 11 e7548 doi:10.1002/ccr3.7548 
 Jannig P. R. Ruas J. L. 2017 target mitochondrial mrna translation 
 tackle obesity-induced insulin resistance thumb exercise Acta Physiol oxf 
 219 14–16 doi:10.1111/apha.12752 
 Jensen C. S. Musaeus C. S. Frikke-Schmidt R. Andersen B. B. Beyer N. Gottrup 
 H. et al. 2020 physical exercise increase plasma concentration high-density 
 lipoprotein-cholesterol patient alzheimer disease Neurosci 14 532 
 doi:10.3389/fnins.2020.00532 
 Jia J. Wei C. Chen S. Li F. Tang Y. Qin W. et al. 2018 cost Alzheimer 
 disease China re-estimation cost worldwide alzheimer Dement 14 483–491 
 doi:10.1016/j.jalz.2017.12.006 
 Kahn B. B. 1996 lilly lecture 1995 glucose transport pivotal step insulin action 
 Diabetes 45 1644–1654 doi:10.2337/diab.45.11.1644 
 Kakoty V. Kc S. Kumari S. Yang C. H. Dubey S. K. Sahebkar A. et al. 2023a 
 brain insulin resistance link alzheimer Parkinson disease pathology 
 undying 
 implication 
 
 epigenetic 
 
 autophagy 
 modulation 
 Inﬂammopharmacology 31 699–716 doi:10.1007/s10787 023 01187-z 
 Kakoty V. Kc S. Yang C. H. Dubey S. K. taliyan R. 2023b explore 
 epigenetic regulated modulation ﬁbroblast growth factor 21 involvement high-fat 
 diet associate Parkinson disease rat acs Chem Neurosci 14 725–740 doi:10 
 1021/acschemneuro.2c00659 
 Kang E. B. Cho J. Y. 2014 effect treadmill exercise brain insulin 
 signaling β-amyloid intracerebroventricular streptozotocin induced-memory 
 impairment rat J. Exerc Nutr biochem 18 89–96 doi:10.5717/jenb.2014.18.1.89 
 Kaspar B. K. Frost L. M. Christian L. Umapathi P. Gage F. H. 2005 synergy 
 insulin-like growth factor-1 exercise amyotrophic lateral sclerosis ann 
 Neurol 57 649–655 doi:10.1002/ana.20451 
 Katsuki a. Yano Y. Sumida Y. ito K. Fujii M. Tsuchihashi K. et al. 1998 
 signiﬁcant decrease insulin secretion diabetic patient clinically probable 
 multiple sclerosis intern Med 37 865–869 doi:10.2169/internalmedicine.37.865 
 Kellar D. Craft S. 2020 brain insulin resistance alzheimer disease 
 related disorder mechanism therapeutic approach lancet Neurol 19 758–766 
 doi:10.1016/S1474 4422(20)30231 3 
 Kelty T. J. Schachtman T. R. Mao X. Grigsby K. B. Childs T. E. Olver T. D. et al. 
 2019 resistance-exercise training ameliorate lps-induced cognitive impairment 
 concurrent molecular signaling change rat dentate gyrus J. appl physiol 
 127 254–263 doi:10.1152/japplphysiol.00249.2019 
 Khalili M. Khamodchyan S. Ayromlou H. Naser-Moghadasi a. 2020 
 insulin resistance related cognition impairment multiple sclerosis patient 
 Multiple Scler Relat disord 37 101575 doi:10.1016/j.msard.2019.11.050 
 Kim S. H. Park S. S. Kim C. J. Kim T. W. 2022 exercise 40-hz light 
 ﬂicker improve hippocampal insulin signaling alzheimer disease mouse J. Exerc 
 Rehabil 18 20–27 doi:10.12965/jer.2244042.021 
 Kleinridders a. Cai W. Cappellucci L. ghazarian a. Collins W. R. Vienberg S. G. et al. 
 2015 insulin resistance brain alter dopamine turnover cause behavioral disorder 
 Proc natl acad Sci U. S. a. 112 3463–3468 doi:10.1073/pnas.1500877112 
 Kouchaki E. Tamtaji O. R. Salami M. Bahmani F. Daneshvar Kakhaki R. Akbari 
 E. et al. 2017 clinical metabolic response probiotic supplementation 
 patient multiple sclerosis randomized double-blind placebo-controlled trial 
 Clin Nutr 36 1245–1249 doi:10.1016/j.clnu.2016.08.015 
 Krumpolec P. Vallova S. Slobodova L. Tirpakova V. Vajda M. Schon M. et al. 
 2017 aerobic-strength exercise improve metabolism clinical state Parkinson 
 disease patient neurology 8 698 doi:10.3389/fneur.2017.00698 
 Kuga G. K. Muñoz V. R. Gaspar R. C. Nakandakari S. da Silva A. S. R. Botezelli 
 J. D. et al. 2018 impaired insulin signaling spatial learning middle-aged rat 
 role ptp1b exp gerontol 104 66–71 doi:10.1016/j.exger.2018.02.005 
 Lalić N. M. Marić J. Svetel M. Jotić A. Stefanova E. Lalić K. et al. 2008 glucose 
 homeostasis Huntington disease abnormality insulin sensitivity early-phase 
 insulin secretion archive Neurology 65 476–480 doi:10.1001/archneur.65.4.476 
 Lee C. J. Sears C. L. Maruthur N. 2020 gut microbiome role obesity 
 insulin resistance ann N. Y. Acad Sci 1461 37–52 doi:10.1111/nyas.14107 
 Lee H. ha T. Y. Jung C. H. Nirmala F. S. Park S. Y. Huh Y. H. et al. 2021 
 mitochondrial dysfunction skeletal muscle contribute development acute insulin 
 resistance mouse J. Cachexia Sarcopenia Muscle 12 1925–1939 doi:10.1002/jcsm.12794 
 Lee J. Pilch P. F. 1994 insulin receptor structure function signaling 
 J. Physiol 266 c319–c334 doi:10.1152/ajpcell.1994.266.2.c319 
 Lei P. Ayton S. Finkelstein D. I. Spoerri L. Ciccotosto G. D. Wright D. K. et al. 
 2012 tau deﬁciency induce parkinsonism dementia impair app- 
 mediated iron export nat med 18 291–295 doi:10.1038/nm.2613 
 LeWitt p. a. 2015 levodopa therapy Parkinson disease pharmacokinetic 
 pharmacodynamic mov Disord 30 64–72 doi:10.1002/mds.26082 
 Li H. Zhou B. Liu J. Li F. Li Y. Kang X. et al. 2015 administration 
 progranulin pgrn trigger er stress impair insulin sensitivity perk-eif2α- 
 dependent manner cell cycle 14 1893–1907 doi:10.1080/15384101.2015.1041686 
 Li M. Chi X. Wang Y. Setrerrahmane S. Xie W. Xu H. 2022 trend 
 insulin resistance insight mechanism therapeutic strategy signal transduct 
 Target Ther 7 216 doi:10.1038/s41392 022 01073 0 
 Li Y. Liu W. Li L. Hölscher C. 2016 neuroprotective effect GIP 
 analogue MPTP Parkinson disease mouse model neuropharmacology 101 
 255–263 doi:10.1016/j.neuropharm.2015.10.002 
 Liu Y. Zhou X. Xiao Y. Li C. Huang Y. Guo Q. et al. 2020 miR-188 promote 
 liver steatosis insulin resistance autophagy pathway J. Endocrinol 245 
 411–423 doi:10.1530/joe-20 0033 
 Luthi-Carter R. Taylor D. M. Pallos J. Lambert E. Amore a. Parker a. et al. 
 2010 sirt2 inhibition achieve neuroprotection decrease sterol biosynthesis 
 Proc natl acad Sci U. S. a. 107 7927–7932 doi:10.1073/pnas.1002924107 
 Lv H. Tang L. Guo C. Jiang Y. Gao C. Wang Y. et al. 2020 intranasal insulin 
 administration highly effective improve cognitive function mouse 
 cognitive dysfunction reverse brain insulin resistance cogn neurodyn 14 
 323–338 doi:10.1007/s11571 020 09571-z 
 Ma T. C. Buescher J. L. Oatis B. Funk J. A. Nash A. J. Carrier R. L. et al. 2007 
 metformin therapy transgenic mouse model Huntington disease neurosci lett 
 411 98–103 doi:10.1016/j.neulet.2006.10.039 
 Mahalakshmi B. Maurya N. Lee S. D. Bharath Kumar V. 2020 possible 
 neuroprotective mechanism physical exercise neurodegeneration int J. Mol Sci 
 21 5895 doi:10.3390/ijms21165895 
 Malin S. K. Stewart N. R. Ude a. a. Alderman B. L. 2022 brain insulin 
 resistance cognitive function inﬂuence exercise J. appl physiol 133 1368–1380 
 doi:10.1152/japplphysiol.00375.2022 
 Marafon B. B. Pinto a. P. Ropelle E. R. de Moura L. P. Cintra D. E. Pauli J. R. 
 et al. 2022 muscle endoplasmic reticulum stress exercise Acta Physiol oxf 235 
 e13799 doi:10.1111/apha.13799 
 Marciniak E. Leboucher a. Caron E. Ahmed T. tailleux a. Dumont J. et al. 
 2017 tau deletion promote brain insulin resistance J. Exp med 214 2257–2269 
 doi:10.1084/jem.20161731 
 Margolis R. U. Altszuler N. 1967 insulin cerebrospinal ﬂuid nature 
 215 1375–1376 doi:10.1038/2151375a0 
 Medina A. Mahjoub Y. Shaver L. pringsheim T. 2022 prevalence 
 incidence huntington disease updated systematic review meta-analysis 
 Mov Disord 37 2327–2335 doi:10.1002/mds.29228 
 Milanski M. Arruda A. P. Coope a. ignacio-souza L. M. Nunez C. E. Roman E. 
 a. et al. 2012 inhibition hypothalamic inﬂammation reverse diet-induced insulin 
 resistance liver diabete 61 1455–1462 doi:10.2337/db11 0390 
 Moosavi M. Naghdi N. Maghsoudi N. Zahedi Asl S. 2006 effect 
 intrahippocampal insulin microinjection spatial learning memory horm 
 Behav 50 748–752 doi:10.1016/j.yhbeh.2006.06.025 
 Frontiers Physiology 
 frontiersin.org 
 14 
 Shen et al. 
 10.3389/fphys.2024.1337442 
 Morris J. K. bomhoff G. L. Stanford J. a. Geiger P. C. 2010 
 neurodegeneration animal model Parkinson disease exacerbate 
 high-fat diet J. Physiol regul integr comp physiol 299 r1082–r1090 doi:10 
 1152/ajpregu.00449.2010 
 Morris J. K. Seim N. B. bomhoff G. L. Geiger P. C. Stanford J. a. 2011 
 effect unilateral nigrostriatal dopamine depletion peripheral glucose tolerance 
 insulin signaling middle aged rat neurosci lett 504 219–222 doi:10.1016/j 
 neulet.2011.09.027 
 Mowry E. Newsome S. Avornu a. Ravenna P. 2017 intranasal insulin 
 improve cognitive function multiple sclerosis multiple Scler J. 18 e130681 
 Nakatsuji H. Araki a. Hashizume a. Hijikata Y. Yamada S. Inagaki T. 
 et al. 2017 correlation insulin resistance motor function spinal 
 bulbar muscular atrophy J. Neurol 264 839–847 doi:10.1007/s00415 017- 
 8405 3 
 Nambron R. Silajdžić E. Kalliolia E. Ottolenghi C. Hindmarsh P. Hill N. R. et al. 
 2016 metabolic study Huntington disease plos 11 e0146480 doi:10.1371/ 
 journal.pone.0146480 
 Nocella C. Cammisotto V. Pigozzi F. borrione P. Fossati C. d’amico a. et al. 
 2019 impairment oxidant antioxidant system short- long-term 
 implication athlete health nutrient 11 1353 doi:10.3390/nu11061353 
 oh J. Park C. Kim S. Kim M. Kim C. S. Jo W. et al. 2023 high level 
 intracellular 
 endotrophin 
 
 adipocyte 
 mediate 
 copii 
 vesicle 
 supply 
 
 autophagosome impair autophagic ﬂux contribute systemic insulin 
 resistance obesity metabolism 145 155629 doi:10.1016/j.metabol.2023.155629 
 Özbeyli D. sarı G. Özkan N. Karademir B. Yüksel M. Çilingir Kaya Ö T. et al. 
 2017 protective effect different exercise modality Alzheimer disease-like 
 model Behav brain res 328 159–177 doi:10.1016/j.bbr.2017.03.044 
 pagel-langenickel I. Bao J. Joseph J. J. Schwartz D. R. Mantell B. S. Xu X. et al. 
 2008 pgc-1alpha integrate insulin signaling mitochondrial regulation 
 bioenergetic function skeletal muscle J. Biol Chem 283 22464–22472 doi:10 
 1074/jbc m800842200 
 Park H. S. Cho H. S. Kim T. W. 2018 physical exercise promote memory 
 capability enhance hippocampal mitochondrial function inhibit apoptosis 
 obesity-induced insulin resistance high fat diet metab Brain Dis 33 283–292 
 doi:10.1007/s11011 017 0160 8 
 Park S. H. Nam G. E. Han K. Huh Y. Kim W. Lee M. K. et al. 2021 
 Association dynamic change metabolic syndrome status risk 
 Parkinson disease nationwide cohort study J. Park dis 11 1751–1759 doi:10 
 3233/jpd-212589 
 Patyn C. 2014 impact high intensity training program glucose tolerance 
 people multiple sclerosis belgium UHasselt 
 Penesova a. Vlcek M. Imrich R. Vernerova L. Marko a. meskova M. et al. 
 2015 hyperinsulinemia newly diagnose patient multiple sclerosis metab 
 Brain Dis 30 895–901 doi:10.1007/s11011 015 9665 1 
 Peng Y. Liu J. Shi L. Tang Y. Gao D. Long J. et al. 2016 mitochondrial 
 dysfunction precede depression ampk/akt signaling insulin resistance induce 
 high glucose primary cortical neuron J. Neurochem 137 701–713 doi:10.1111/ 
 jnc.13563 
 Perruolo G. Viggiano D. Fiory F. cassese a. Nigro C. Liotti a. et al. 2016 
 parkinson-like phenotype insulin-resistant ped/pea-15 transgenic mouse sci Rep. 6 
 29967 doi:10.1038/srep29967 
 Perurena O. H. Festoff B. W. 1987 reduction insulin receptor 
 amyotrophic lateral sclerosis correlate reduce insulin sensitivity neurology 
 37 1375–1379 doi:10.1212/wnl.37.8.1375 
 Pessin J. E. Thurmond D. C. Elmendorf J. S. Coker K. J. Okada S. 1999 
 molecular basis insulin-stimulated glut4 vesicle trafﬁcking location location 
 location J. Biol Chem 274 2593–2596 doi:10.1074/jbc.274.5.2593 
 Phillips O. R. Onopa a. K. Zaiko Y. V. Singh M. K. 2018 insulin resistance 
 associate small brain volume preliminary study depressed obese 
 child pediatr diabete 19 892–897 doi:10.1111/pedi.12672 
 Poewe W. Seppi K. 2017 insulin signalling new target Parkinson 
 treatment lancet 390 1628–1630 doi:10.1016/s0140 6736(17)32101 3 
 Pradat P. F. Bruneteau G. Gordon P. H. Dupuis L. Bonnefont-Rousselot D. 
 Simon D. et al. 2010 impaired glucose tolerance patient amyotrophic lateral 
 sclerosis amyotroph Lateral Scler 11 166–171 doi:10.3109/17482960902822960 
 Rabinowitz D. Zierler K. L. 1962 forearm metabolism obesity 
 response intra-arterial insulin characterization insulin resistance evidence 
 adaptive hyperinsulinism J. Clin invest 41 2173–2181 doi:10.1172/jci104676 
 Radikova Z. Penesova a. Vlcek M. Havranova A. Sivakova M. Siarnik P. et al. 
 2018 ldl hdl lipoprotein subfraction multiple sclerosis patient 
 decrease insulin sensitivity endocr regul 52 139–145 doi:10.2478/enr-2018 0017 
 Rahmati M. Keshvari M. Mirnasouri R. Chehelcheraghi F. 2021 exercise 
 Urtica dioica extract ameliorate hippocampal insulin signaling oxidative stress 
 neuroinﬂammation cognitive function stz-induced diabetic rat biome 
 Pharmacother 139 111577 doi:10.1016/j.biopha.2021.111577 
 Reger M. a. Watson G. S. Green P. S. Baker L. D. Cholerton B. Fishel M. a. 
 et al. 2008a intranasal insulin administration dose-dependently modulate verbal 
 memory plasma amyloid-beta memory-impaired old adult J. Alzheimers Dis 
 13 323–331 doi:10.3233/jad-2008 13309 
 Reger M. a. Watson G. S. Green P. S. Wilkinson C. W. Baker L. D. Cholerton B. 
 et al. 2008b intranasal insulin improve cognition modulate beta-amyloid 
 early ad neurology 70 440–448 doi:10.1212/01.wnl.0000265401.62434.36 
 Reyes E. T. Perurena O. H. Festoff B. W. Jorgensen R. Moore W. V. 1984 
 insulin resistance amyotrophic lateral sclerosis J. Neurol Sci 63 317–324 doi:10 
 1016/0022 510x(84)90154 0 
 Roberts C. K. Hevener A. L. Barnard R. J. 2013 metabolic syndrome 
 insulin resistance underlie cause modiﬁcation exercise training compr 
 Physiol 3 1–58 doi:10.1002/cphy.c110062 
 rodriguez-araujo G. Nakagami H. Takami Y. Katsuya T. Akasaka H. Saitoh S. 
 et al. 2015 low alpha-synuclein level blood associate insulin 
 resistance sci Rep. 5 12081 doi:10.1038/srep12081 
 Rorato R. Borges B. C. Uchoa E. T. Antunes-Rodrigues J. Elias C. F. Elias L. 
 L. K. 2017 lps-induced low-grade inﬂammation increase hypothalamic jnk 
 expression cause central insulin resistance irrespective body weight change 
 int J. Mol Sci 18 1431 doi:10.3390/ijms18071431 
 Rothstein J. D. 2017 edaravone new drug approve als cell 171 725 doi:10 
 1016/j.cell.2017.10.011 
 Rudnicka E. Napierała P. Podﬁgurna a. Męczekalski B. Smolarczyk R. 
 Grymowicz M. 2020 World Health Organization approach healthy 
 ageing maturita 139 6–11 doi:10.1016/j.maturitas.2020.05.018 
 Ruegsegger G. N. Creo A. L. Cortes T. M. Dasari S. Nair K. S. 2018 altered 
 mitochondrial function insulin-deﬁcient insulin-resistant state J. Clin invest 
 128 3671–3681 doi:10.1172/jci120843 
 Ruegsegger G. N. Vanderboom P. M. Dasari S. Klaus K. a. Kabiraj P. McCarthy 
 C. B. et al. 2019 exercise metformin counteract altered mitochondrial function 
 insulin-resistant brain jci insight 4 e130681 doi:10.1172/jci.insight.130681 
 Ruiz-Argüelles a. Méndez-Huerta M. a. Lozano C. D. Ruiz-Argüelles G. J. 
 2018 metabolomic proﬁle insulin resistance patient multiple sclerosis 
 associate severity disease mult scler Relat disord 25 316–321 doi:10 
 1016/j.msard.2018.08.014 
 Russo C. V. Salvatore E. Saccà F. Tucci T. Rinaldi C. sorrentino P. et al. 2013 
 insulin sensitivity early-phase insulin secretion normoglycemic Huntington 
 disease patient J. Huntingt dis 2 501–507 doi:10.3233/jhd-130078 
 Sadegh S. Golestany a. 2017 effect 10 week aerobic training water 
 chemerin insulin resistance woman multiple sclerosis intern med 
 today 23 226–234 
 sánchez-gómez a. alcarraz-vizán G. Fernández M. Fernández-Santiago R. 
 Ezquerra M. Cámara a. et al. 2020 peripheral insulin amylin level 
 Parkinson disease park Relat disord 79 91–96 doi:10.1016/j.parkreldis.2020.08.018 
 Sangwung P. Petersen K. F. Shulman G. I. Knowles J. W. 2020 
 mitochondrial dysfunction insulin resistance potential genetic implication 
 endocrinology 161 bqaa017 doi:10.1210/endocr/bqaa017 
 Schiöth H. B. Frey W. H. Brooks S. J. Benedict C. 2012 insulin treat 
 Alzheimer disease follow nose Expert Rev. Clin Pharmacol 5 17–20 
 doi:10.1586/ecp.11.70 
 Schubert M. Brazil D. P. Burks D. J. Kushner J. a. ye J. Flint C. L. et al. 2003 insulin 
 receptor substrate-2 deﬁciency impair brain growth promote tau phosphorylation 
 J. Neurosci 23 7084–7092 doi:10.1523/jneurosci.23 18 07084.2003 
 Schubert M. Gautam D. Surjo D. Ueki K. Baudler S. Schubert D. et al. 2004 
 Role neuronal insulin resistance neurodegenerative disease proc natl acad Sci 
 U. S. a. 101 3100–3105 doi:10.1073/pnas.0308724101 
 Sharma S. taliyan R. 2018 high fat diet feeding induce insulin resistance 
 exacerbate 6-ohda mediate neurotoxicity behavioral abnormality rat 
 Behav brain res 351 17–23 doi:10.1016/j.bbr.2018.05.025 
 Shi H. Kokoeva M. V. Inouye K. Tzameli I. Yin H. Flier J. S. 2006 
 tlr4 link innate immunity fatty acid-induced insulin resistance J. Clin invest 
 116 3015–3025 doi:10.1172/jci28898 
 Shimizu T. Honda M. Ohashi T. Tsujino M. Nagaoka U. Kawata a. et al. 
 2011 hyperosmolar hyperglycemic state advanced amyotrophic lateral sclerosis 
 amyotroph Lateral Scler 12 379–381 doi:10.3109/17482968.2010.539234 
 Shoelson S. E. Lee J. Goldﬁne A. B. 2006 inﬂammation insulin 
 resistance J. Clin invest 116 1793–1801 doi:10.1172/jci29069 
 Shonesy 
 B. 
 C. 
 Thiruchelvam 
 K. 
 Parameshwaran 
 K. 
 Rahman 
 E. 
 a. 
 Karuppagounder S. S. Huggins K. W. et al. 2012 central insulin resistance 
 synaptic 
 dysfunction 
 
 intracerebroventricular-streptozotocin 
 inject 
 rodent 
 Neurobiol aging 33 430.e435–18 doi:10.1016/j.neurobiolaging.2010.12.002 
 Siddiqui N. Ali J. Parvez S. Zameer S. Najmi a. K. Akhtar M. 2021 
 Linagliptin 
 
 dpp-4 
 inhibitor 
 ameliorate 
 Aβ 
 1 42 
 peptide 
 induce 
 neurodegeneration brain insulin resistance bir insulin receptor substrate- 
 Frontiers Physiology 
 frontiersin.org 
 15 
 Shen et al. 
 10.3389/fphys.2024.1337442 
 1 irs-1 rat model alzheimer disease neuropharmacology 195 108662 doi:10 
 1016/j.neuropharm.2021.108662 
 Sims-Robinson C. Bakeman A. Glasser R. Boggs J. Pacut C. Feldman E. L. 
 2016 role endoplasmic reticulum stress hippocampal insulin resistance 
 Exp neurol 277 261–267 doi:10.1016/j.expneurol.2016.01.007 
 Soke F. Kocer B. Fidan I. Keskinoglu P. guclu-gunduz a. 2021 effect 
 task-oriented training combine aerobic training serum bdnf gdnf igf-1 
 VEGF tnf-α il-1β level people Parkinson disease randomized 
 controlled study exp gerontol 150 111384 doi:10.1016/j.exger.2021.111384 
 Soliman R. H. Farhan H. M. hegazy M. Oraby M. I. Kamel S. H. Hassan a. 
 2020 impact insulin resistance metabolic syndrome disability patient 
 multiple sclerosis egypt J. Neurology Psychiatry Neurosurg 56 18 doi:10.1186/ 
 s41983 020 0155-y 
 Song J. Kang S. M. Kim E. Kim C. H. Song H. T. Lee J. E. 2015 
 Impairment insulin receptor substrate 1 signaling insulin resistance inhibit 
 neurite outgrowth aggravate neuronal cell death neuroscience 301 26–38 doi:10 
 1016/j.neuroscience.2015.05.072 
 Speziale R. Montesano C. Di Pietro G. cicero D. O. summa V. Monteagudo E. 
 et al. 2023 urine metabolome r6/2 zQ175DN Huntington disease mouse 
 model metabolite 13 961 doi:10.3390/metabo13080961 
 Spielman L. J. little J. P. Klegeris a. 2014 inﬂammation insulin/igf- 
 1 
 resistance 
 
 
 possible 
 link 
 
 obesity 
 
 neurodegeneration 
 J. Neuroimmunol 273 8–21 doi:10.1016/j.jneuroim.2014.06.004 
 Stenvers D. J. Scheer F. Schrauwen P. la Fleur S. E. Kalsbeek a. 2019 
 circadian clock insulin resistance nat Rev. Endocrinol 15 75–89 doi:10.1038/ 
 s41574 018 0122 1 
 Stuckenschneider T. Abeln V. Foitschik T. Abel T. Polidori M. C. Strüder 
 H. K. 2021 disease-inclusive exercise class improve physical ﬁtness reduce 
 depressive symptom individual Parkinson disease-a feasibility 
 study brain Behav 11 e2352 doi:10.1002/brb3.2352 
 Sujkowski a. Hong L. Wessells R. J. Todi S. V. 2022 protective role 
 exercise age-related neurodegeneration ageing res rev. 74 101543 doi:10 
 1016/j.arr.2021.101543 
 Szymura J. Kubica J. Wiecek M. Pera J. 2020 immunomodulary effect 
 systematic exercise old adult people Parkinson disease J. Clin med 
 9 184 doi:10.3390/jcm9010184 
 Talbot K. Wang H. Y. Kazi H. Han L. Y. Bakshi K. P. Stucky a. et al. 2012 
 demonstrated brain insulin resistance alzheimer disease patient associate 
 igf-1 resistance irs-1 dysregulation cognitive decline J. Clin invest 122 
 1316–1338 doi:10.1172/jci59903 
 Tang X. Shen H. Chen J. Wang X. Zhang Y. Chen L. L. et al. 2011 activate 
 transcription 
 factor 
 6 
 protect 
 insulin 
 receptor 
 
 er 
 stress-stimulated 
 desensitization p42/44 erk pathway Acta Pharmacol sin 32 1138–1147 
 doi:10.1038/aps.2011.75 
 Lancet N. 2021 multiple sclerosis spotlight Lancet Neurol 20 497 
 doi:10.1016/S1474 4422(21)00170 8 
 Tiganis T. 2011 reactive oxygen specie insulin resistance good bad 
 ugly trend Pharmacol Sci 32 82–89 doi:10.1016/j.tips.2010.11.006 
 Tsai C. P. Hu C. Lee C. T. 2019 find disease associate 
 amyotrophic 
 lateral 
 sclerosis 
 
 total 
 population-based 
 case-control 
 study 
 amyotroph Lateral Scler degener 20 82–89 doi:10.1080/21678421.2018 
 1522354 
 um H. S. Kang E. B. Leem Y. H. Cho I. H. Yang C. H. Chae K. R. et al. 2008 
 exercise training act therapeutic strategy reduction pathogenic 
 phenotype alzheimer disease nse/appsw-transgenic model int J. Mol 
 Med 22 529–539 
 United Nations Population Division 2002 aging world population 1950- 
 2050 United Nations Publications 1–483 
 Waldron A. M. Wintmolders C. Bottelbergs a. Kelley J. B. Schmidt M. E. 
 Stroobants S. et al. 2015 vivo molecular neuroimaging glucose utilization 
 association ﬁbrillar amyloid-β load aged appps1 21 mouse alzheimer res ther 
 7 76 doi:10.1186/s13195 015 0158 6 
 Wang M. Zhang H. Liang J. Huang J. Chen N. 2023 exercise suppress 
 neuroinﬂammation alleviate Alzheimer disease J. Neuroinﬂammation 20 76 
 doi:10.1186/s12974 023 02753 6 
 Wang Y. Hu Y. Sun C. Zhuo S. Z. Wang H. et al. 2016 down-regulation 
 Risa improve insulin sensitivity enhance autophagy faseb J. 30 3133–3145 
 doi:10.1096/fj.201500058R 
 Watson G. S. Peskind E. R. Asthana S. Purganan K. Wait C. Chapman D. et al. 
 2003 insulin increase csf abeta42 level normal old adult neurology 60 
 1899–1903 doi:10.1212/01.wnl.0000065916.25128.25 
 Wens I. Dalgas U. Vandenabeele F. Verboven K. Hansen D. Deckx N. et al. 
 2017 high intensity aerobic resistance exercise improve glucose tolerance 
 person multiple sclerosis randomized control trial J. Phys med 
 Rehabil 96 161–166 doi:10.1097/phm.0000000000000563 
 Wens I. Hansen D. Verboven K. Deckx N. Kosten L. Stevens A. L. et al. 2015 
 impact 24 week resistance endurance exercise glucose tolerance person 
 multiple sclerosis J. Phys med Rehabil 94 838–847 doi:10.1097/phm 
 0000000000000257 
 Werther G. a. Hogg a. Oldﬁeld B. J. McKinley M. J. Figdor R. Mendelsohn 
 F. a. 1989 localization characterization insulin-like growth factor-i receptor 
 rat brain pituitary gland vitro autoradiography computerize 
 densitometry distinct distribution insulin receptor J. Neuroendocrinol 1 
 369–377 doi:10.1111/j.1365 2826.1989.tb00131.x 
 Wijtenburg S. a. Kapogiannis D. korenic S. a. Mullins R. J. Tran J. Gaston F. E. 
 et al. 2019 brain insulin resistance altered brain glucose related memory 
 impairment schizophrenia schizophr res 208 324–330 doi:10.1016/j.schres.2019 
 01.031 
 Willette a. a. Johnson S. C. Birdsill A. C. Sager M. a. christian B. Baker L. D. 
 et al. 2015 insulin resistance predict brain amyloid deposition late middle-aged 
 adult alzheimer Dement 11 504–510 doi:10.1016/j.jalz.2014.03.011 
 Williams K. W. Liu T. Kong X. Fukuda M. Deng Y. Berglund E. D. et al. 2014 
 xbp1s pomc neuron connect er stress energy balance glucose 
 homeostasis cell Metab 20 471–482 doi:10.1016/j.cmet.2014.06.002 
 Woods S. C. Seeley R. J. Baskin D. G. Schwartz M. W. 2003 insulin 
 blood-brain barrier curr pharm Des 9 795–800 doi:10.2174/1381612033455323 
 Wu H. Wang Y. Li W. Chen H. Du L. Liu D. et al. 2019 deﬁciency 
 mitophagy receptor fundc1 impair mitochondrial quality aggravate dietary- 
 induced obesity metabolic syndrome autophagy 15 1882–1898 doi:10.1080/ 
 15548627.2019.1596482 
 Xie L. Helmerhorst E. Taddei K. Plewright B. Van Bronswijk W. 
 Martins R. 2002 alzheimer beta-amyloid peptide compete insulin 
 binding 
 
 
 insulin 
 receptor 
 J. 
 Neurosci 
 22 
 rc221 
 doi:10.1523/ 
 JNEUROSCI.22 10-j0001.2002 
 xin W. Li Z. Xu Y. Yu Y. Zhou Q. Chen L. et al. 2016 autophagy protect 
 human podocyte high glucose-induced injury prevent insulin resistance 
 metabolism 65 1307–1315 doi:10.1016/j.metabol.2016.05.015 
 Xu L. Liu T. Liu L. Yao X. Chen L. Fan D. et al. 2020 global variation 
 prevalence incidence amyotrophic lateral sclerosis systematic review meta- 
 analysis J. Neurol 267 944–953 doi:10.1007/s00415 019 09652-y 
 Yang L. Li P. Fu S. Calay E. S. Hotamisligil G. S. 2010 defective hepatic 
 autophagy obesity promote er stress cause insulin resistance cell Metab 11 
 467–478 doi:10.1016/j.cmet.2010.04.005 
 Yang L. Zhang X. Li S. Wang H. Zhang X. Liu L. et al. 2020 intranasal insulin 
 ameliorate cognitive impairment rat model Parkinson disease akt/ 
 gsk3β signaling pathway life Sci 259 118159 doi:10.1016/j.lfs.2020.118159 
 Yano H. Seino Y. Inagaki N. Hinokio Y. Yamamoto T. Yasuda K. et al. 1991 
 tissue distribution specie difference brain type glucose transporter 
 glut3 
 Biochem 
 Biophys 
 res 
 Commun 
 174 
 470–477 
 doi:10.1016/0006- 
 291x(91)91440-n 
 Yao T. Deng Z. Gao Y. Sun J. Kong X. Huang Y. et al. 2017 ire1α pomc 
 neuron require thermogenesis glycemia diabete 66 663–673 doi:10.2337/ 
 db16 0533 
 Yoon S. O. Park D. J. Ryu J. C. Ozer H. G. Tep C. Shin Y. J. et al. 2012 
 jnk3 perpetuate metabolic stress induce aβ peptide neuron 75 824–837 doi:10 
 1016/j.neuron.2012.06.024 
 Zabielski P. Lanza I. R. Gopala S. Heppelmann C. J. Bergen H. R. Dasari S. 
 et al. 2016 altered skeletal muscle mitochondrial proteome basis 
 disruption mitochondrial function diabetic mouse diabete 65 561–573 
 doi:10.2337/db15 0823 
 Zhang H. Liang J. L. Wu Q. Y. Li J. X. Liu Y. Wu L. W. et al. 2022b swim 
 suppress 
 cognitive 
 decline 
 
 hfd-induced 
 obese 
 mouse 
 
 reverse 
 hippocampal inﬂammation insulin resistance bdnf level nutrient 14 2432 
 doi:10.3390/nu14122432 
 Zhang W. Hietakangas V. Wee S. Lim S. C. Gunaratne J. Cohen S. M. 
 2013 er stress potentiate insulin resistance perk-mediated FOXO 
 phosphorylation gene dev 27 441–449 doi:10.1101/gad.201731.112 
 Zhang Y. Wang R. Fu X. Song H. 2022a non-insulin-base insulin 
 resistance index predict severity coronary artery disease diabetol 
 Metab Syndr 14 191 doi:10.1186/s13098 022 00967-x 
 Zhao W. Q. Chen H. Quon M. J. Alkon D. L. 2004 insulin insulin 
 receptor experimental model learning memory eur J. Pharmacol 490 
 71–81 doi:10.1016/j.ejphar.2004.02.045 
 Zhou L. Zhang J. Fang Q. Liu M. Liu X. Jia W. et al. 2009 autophagy- 
 mediated insulin receptor down-regulation contribute endoplasmic reticulum 
 stress-induced insulin resistance mol pharmacol 76 596–603 doi:10.1124/mol.109 
 057067 
 Zorov D. B. Juhaszova M. Sollott S. J. 2014 mitochondrial reactive oxygen 
 specie ros ros-induced ros release physiol rev. 94 909–950 doi:10.1152/ 
 physrev.00026.2013 
 Frontiers Physiology 
 frontiersin.org 
 16 
 Shen et al. 
 10.3389/fphys.2024.1337442 
